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      Iodotyrosine deiodinase (IYD) serves a critical role in iodide conservation through 
salvage of iodide from mono- and diiodotyrosine (I-Tyr and I2-Tyr), the by-products of 
thyroid hormone (TH) synthesis. Genomic data suggested the presence of this enzyme in 
a wide range of organisms including non-chordate invertebrates as well as prokaryotes. 
These organisms are not associated with TH signaling. A representative set of IYD 
homologs from these organisms with conserved key residues were expressed, purified 
and shown to catalyze deiodination of I2-Tyr with comparable catalytic efficiencies 
(kcat/Km). Our findings implied that the origins of IYD predate the evolution of TH 
signaling and suggested alternative physiological roles for IYD in non-chordate 
invertebrates.  
     The IYD homolog from the model non-chordate invertebrate Drosophila 
melanogaster (dmIYD) displayed little discrimination between iodo-, bromo- and 
chlorotyrosine as substrates in vitro since all exhibited similar affinities and comparable 
efficiencies of dehalogenation. Additionally, active site mutants of dmIYD revealed a 
glutamate to be most critical for catalysis followed by a lysine while substitution of a 
tyrosine was least perturbing. These findings should further facilitate annotation of 
genomic data for potential halotyrosine dehalogenases.  
     The in vivo function of the dehalogenase in non-chordate invertebrates is unknown. 
Prior expression profiling of mRNA in Drosophila indicated that testes expressed the 
highest level of the dehalogenase encoding gene (CG6279). This was confirmed through 
in situ hybridization experiments suggesting a biological role for CG6279 in 
spermatogenesis. However, deletion of the CG6279 gene (CG6279Del) as well as 
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introduction of a loss of function amino acid substitution in the dehalogenase domain 
(CG6279E154Q) using CRISPR/Cas9 gene editing did not significantly affect the fertility 
of male Drosophila. This indicated that the dehalogenase gene is not critical for 
spermatogenesis. 
     Previous studies demonstrated I-Tyr to be toxic to Drosophila larvae. To assess 
whether loss of function mutations in CG6279 increases larval sensitivity to I-Tyr 
toxicity, 1st instar larvae from both CG6279 mutant strains were raised on media 
supplemented with I-Tyr and survival to adulthood was evaluated. CG6279E154Q larvae 
displayed significantly lower survival rates in presence of I-Tyr compared to controls 
indicating increased sensitivity to I-Tyr toxicity. However, CG6279Del larvae were 
significantly less sensitive to I-Tyr toxicity leading to uncertainty whether the 
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Chapter 1: Introduction 
1.1 Iodine is an essential micronutrient  
     Iodine is critical for human health. A lack of iodine may lead to goiter (enlargement of 
the thyroid) and thyroid hormone (TH) deficiency which can result in serious 
developmental disorders in early childhood.1,2 Intake of iodine recommended by the World 
Health Organization for humans 12 years and above is about 150 µg per day.2 Despite this 
relatively small requirement, iodine can be hard to come by since it is the least abundant 
halogen in the earth’s crust and its concentration is especially low in mountainous and 
inland areas.1,3 Even the concentration of iodine in the oceans (as iodide or I-) is quite low 
and estimated to be about 50 µg/L.1,4  
     Iodine is essential for the synthesis of THs namely 3,3’,5,5’-tetraiodothyronine (T4) and 
3,3’,5-triiodothyronine (T3) (Fig. 1-1).2 THs are critical for vertebrate development. In 
mammals, they regulate growth, development, differentiation of nervous tissue and the 
basal metabolic rate.5 In non-mammalian vertebrates such as amphibians, THs play a 
critical role in regulating metamorphosis.6 Removal of the thyroid in amphibian larvae has 
been shown to prevent metamorphosis.7 In bony fish like the zebrafish, THs control 
development from the early embryonic stages.8 Even chordate invertebrates such as the 
amphioxus (lancelet) have an endostyle (an evolutionary precursor of thyroid) and likely 





                     
Figure 1-1. Thyroid hormones T4 and T3 along with diiodotyrosine (I2-Tyr) and 
monoiodotyrosine (I-Tyr).   
 
1.2 Iodide uptake and conservation 
     Mammals have evolved to efficiently conserve and recycle iodide (Fig. 1-2). It is 
concentrated in thyroid follicular cells through active transport by the sodium/iodide 
symporter (NIS), a basal membrane bound glycoprotein.11 This results in a 20 to 40-fold 
higher concentration of I- within the thyroid follicular cells compared to plasma.12 I- is then 
transported to the colloid through the apical membrane where it is coupled to tyrosine 
residues on thyroglobulin in the colloid by thyroid peroxidase (TPO). TPO also couples 
adjacent iodinated tyrosines to produce TH precursors.13 The thyroglobulin then undergoes 
endocytosis into the follicular cell where it is degraded to release one molecule of TH along 
with an estimated 7 molecules of monoiodotyrosine (I-Tyr) and about 6 molecules of 
diiodotyrosine (I2-Tyr) that are iodinated by-products of TH synthesis (Fig 1-1).13 I-Tyr 
and I2-Tyr cannot be directly reused for TH synthesis but iodotyrosine deiodinase (IYD) 
can salvage I- from these by-products of TH synthesis.14 IYD is essential for maintaining 




                  
    Figure 1-3. Deiodination of I-Tyr and I2-Tyr catalyzed by IYD.  
      
The origins of these two enzymes are quite different despite their ability to catalyze similar 
reactions. Unlike IYD that relies on a flavin cofactor, ID catalyzes deiodination of THs 
through an active site selenocysteine. ID belongs to the thioredoxin superfamily22 while 
IYD on the other hand belongs to the nitro-FMN reductase superfamily (previously 
referred to as the NADH oxidase/flavin reductase superfamily).23  
     Sequence analysis of mammalian IYDs revealed the presence of an N-terminal 
membrane anchor, an intermediate domain that displays higher variability and lacks 
homology to known protein domains and a C-terminal catalytic domain that is well 
conserved and displays homology to members of the nitro-FMN reductase superfamily.23 
Although many nitroreductases are able to utilize reduced nicotinamides (NADH or 
NADPH) directly as co-substrates,24 IYD is thought to derive its reducing equivalents in 






Figure 1-4. The N-terminal membrane domain (A), intermediate domain (B) and catalytic 
domain (C) of mouse IYD. Amino acid numbers for the predicted domain boundaries are 
indicated above. Figure is adapted from Friedman et al.23  
 
1.4 Isolation and expression of IYD 
     The first successful attempt to isolate IYD from bovine thyroid microsomes was 
reported 47 years ago for which an enzymatic treatment (steapsin lipase) or detergent was 
used to solubilize the enzyme. This was followed by ammonium sulfate precipitation and 
multiple chromatographic separation procedures.18 The protocol was tedious and hard to 
replicate.23 Between 2004 and 2008, heterologous expression of IYD was reported in 
mammalian cell cultures.14,23,25 A membrane domain truncated (ΔTM, amino acids 2-33), 
C-terminally His tagged version of mouse (mm) IYD (mmIYD ΔTM, His6) was expressed 
in a soluble form in mammalian cell cultures.25 It retained catalytic activity with dithionite 
as reductant but activity with NADPH was suppressed indicating the membrane anchor 
might be essential for interaction with the putative reductase.25 Further truncation of 
mmIYD up to its catalytic domain resulted in insoluble and catalytically inactive enzyme.26 
Sufficient yield of soluble enzyme from mammalian cultures remained elusive. Finally, 
expression of mmIYD (ΔTM, His6) in yeast (Pichia pastoris) and insect cell (Sf9) cultures 
resulted in soluble and catalytically active IYD in sufficient quantities to allow purification 
to homogeneity by Ni2+ affinity chromatography.27  Sf9 expression provided higher yields 
of enzyme than yeast expression enabling crystallographic studies on the enzyme.28  
A B C 
1 24 82 285 
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     Eukaryotic cell lines are more difficult to grow, maintain and perform routine genetic 
manipulations. Therefore, an alternative prokaryotic expression system for IYD was 
desired. Initial attempts at expressing mmIYD (ΔTM, His6) in E. coli yielded insoluble 
protein despite attempting N-terminal fusions with multiple protein tags known to enhance 
solubility.29,30 Additional mutations of Cys residues to Ala along with an N-terminal 
thioredoxin fusion finally provided soluble expression of a catalytically active IYD in E. 
coli in sufficient quantities to enable crystallographic studies as reported in 2012.29 
Subsequently, E. coli expression of N-terminal SUMO fusion of human (hs) IYD (ΔTM, 
His6) as well as IYD homologs from other organisms such as zebrafish, honeybee and 
lancelet yielded soluble protein in sufficient yields to enable purification and 





Figure 1-5. Design of SUMO fusion expression vector pSMT332 with the IYD gene. T7 is 
the promoter for expression and H6 is the His6 affinity tag for Ni2+ affinity purification. 
BamH1 and Xho1 are restriction sites used to clone IYD genes into the vector. Figure is 
adapted from Buss J. M., PhD Dissertation.30 
 
1.5 Relationship between IYD and other superfamily members 
     The nitro-FMN reductase superfamily is comprised of bacterial flavoproteins that 
catalyze diverse redox reactions of varied substrates including the reduction of 
nitroaromatics. IYD is the only known mammalian member of this superfamily.24 The 
crystal structure of mmIYD reported in 2009 resulted in major advances in understanding 




enzyme-substrate interactions and its relationship to other members within the nitro-FMN 
reductase superfamily.28 Similar to other members of the superfamily, IYD exhibits an α-
β fold with a dimer comprised of identical subunits that display domain swapping and an 
extensive dimer interface that includes the active site of the enzyme (Fig. 1-6).  
                           
Figure 1-6. The co-crystal structure of mmIYD·I-Tyr (PBD ID 3GFD). The two identical 
polypeptides are indicated in green and red, respectively. FMN and I-Tyr in the active sites 
are indicated in yellow and purple respectively. 
 
     Within the superfamily, IYD is structurally most similar to BluB, a flavin destructase 
that degrades FMN to produce 5,6-dimethylbenzimidazole, the lower ligand of vitamin 
B12.33 Both IYD and BluB form a distinct subclass within the superfamily as their active 
site lids are derived from the same region of their primary structure.28 The other two 
subclasses are represented by NADH oxidase (NOX) that accepts electrons from reduced 
nicotinamides for transfer to various acceptors34 and by flavin reductase P (FRP) that 
provides reduced flavins for the luciferase activity.35 The active site lid of these latter two 
enzymes is derived from different regions of their primary structure.28 The presence of an 
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iodide salvage enzyme that functions in the mammalian thyroid within this superfamily of 
bacterial enzymes was not obvious and intriguing given its unusual recruitment of a flavin 
cofactor for dehalogenation. 
1.6 IYD is more widespread than suggested by its known function of iodide salvage 
     IYD is primarily associated with iodide salvage and maintaining iodide homeostasis for 
thyroid hormone production.13,36 However, the Basic Local Alignment and Search Tool 
(BLAST)37 identified homologous proteins in diverse organisms including lower 
invertebrates such as arthropods (insects and crustaceans) and cnidarians (primitive marine 
organisms displaying radial symmetry including anemones, hydroids, jellies and corals).30 
Organisms belonging to these phyla lack the thyroid gland and are not known to synthesize 
THs endogenously. These findings suggested that the origins of IYD likely pre-date the 
evolution of TH signaling. Iodinated tyrosines have been proposed as possible evolutionary 
precursors of thyroid hormones38 and IYD thus has the potential to serve as a marker to 
trace the origins of signaling via iodinated compounds.  
     A prerequisite for identifying additional IYDs throughout multiple phyla within 
different kingdoms in the tree of life is a robust set of determinants indicative of this 
enzymatic activity.  
1.7 Specific Aims 
     Within the past decade, significant progress has been made in understanding the 
mechanism of dehalogenation promoted by IYD as well as interactions between the 
protein, FMN cofactor and substrate. Most studies published to date have been focused on 
mammalian enzymes. However, this enzyme likely has origins that pre-date its function in 
mammals. Identification of more primitive IYD homologs present the opportunity to 
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investigate its biological function prior to evolution of THs. Additionally, more primitive 
IYD homologs may exhibit broader substrate specificities enabling applications in 
bioremediation of halogenated aromatics. My first research objective was to investigate the 
origins of IYD within the nitro-FMN reductase superfamily through identification of 
signature residues that are markers for iodotyrosine deiodinase activity. My second 
research objective was to study the biological function of IYD in an invertebrate model 
organism not known to synthesize THs and hence having no known need for iodide 
salvage. This dissertation describes the following: 
     1) Identification of an amino acid signature that is a robust indicator of deiodinase 
activity derived from available crystallographic data, bioinformatics and phylogenetic 
analysis. Application of this signature sequence to test its predictive power through 
heterologous expression and catalytic characterization of IYD homologs across diverse 
phyla from eukaryotes to prokaryotes.  
     2) In vitro characterization of the IYD homolog from the model invertebrate Drosophila 
melanogaster not known to require iodide and lacking in TH synthesis. This includes 
probing the halotyrosine substrate specificity as well as site directed mutagenesis of highly 
conserved active site residues and its impact on substrate recognition and catalysis. 
     3) Investigation of the biological role of Drosophila IYD through loss of function 
studies including IYD gene silencing using RNA interference as well as gene editing using 
CRISPR/Cas9. 
    4) Probing the in vivo activity of Drosophila IYD though assessment of halotyrosine 
toxicity upon feeding halotyrosines to wild-type and IYD null mutants generated through 
gene editing by CRISPR/Cas9.    
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Chapter 2: Refining the signature sequence for IYD activity through 
heterologous expression and characterization of IYD homologs 
2.1 Introduction 
     An enzyme superfamily generally represents a large group of proteins that are 
evolutionarily related to each other and have likely diverged from a common ancestor to 
perform specialized functions.39 Members of a superfamily sharing structural similarities 
can catalyze diverse reactions and process diverse substrates.40 Proteins of a superfamily 
can often be further organized into subgroups based on certain conserved sequence motifs 
and are thought to catalyze similar reactions. With ever increasing number of genomes 
from prokaryotes as well as eukaryotes being rapidly sequenced, proteins are being added 
to databases much faster than they can be analyzed for activity and therefore biochemical 
characterization of only a small fraction of all proteins from databases has been 
accomplished thus far. Annotation of newly added proteins is most often only predicted 
through computational methods. Automated annotation tools generally assign proteins to 
the correct superfamily. However, they are less accurate at assigning correct catalytic 
function.41,42 
     New protein sequences added to the nitro-FMN reductase superfamily are often broadly 
annotated as nitroreductases without accounting for the catalytic diversity of the members 
of this superfamily that includes iodotyrosine deiodinases (IYD), flavin destructases 
(BluB), flavin reductases (FRP) and NADH oxidases (NOX) among others as described in 
the previous chapter. Correct annotation of the plethora of new sequences will be crucial 
towards discovery of newer substrate specificities, potential applications in biomedical 
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research such as prodrug activation by nitroreductases in cancer therapy24 and in 
bioremediation of halogenated aromatics.19 
    The co-crystal structure of mm IYD with its substrate I2-Tyr identified key interactions 
between protein residues, substrate and cofactor and provided the opportunity to identify a 
signature sequence that should be diagnostic of IYD enzymes within the nitro-FMN 
reductase superfamily. The side chains of Glu-153, Tyr-157 and Lys-178 interact with 
substrate zwitterion28 and are not present in BluB, the closest structural relative of IYD.33 
The amide nitrogen of Ala-126 donates a hydrogen bond to the substrate phenolate and is 
replaced by Gly-61 at an equivalent position in BluB. The OH group of Thr-235 hydrogen 
bonds with O4 and N5of FMN and a similar interaction is provided by Ser-167 in BluB. A 
side chain hydrogen bonding interaction with flavin N5 has not yet been tested in other 
members of the superfamily.  
 
          
 
Figure 2-1. Active site of mmIYD indicating the flavin cofactor (FMN), diiodotyrosine 
(I2-Tyr) and residues interacting with cofactor and substrate (PDB ID 3GH8).28 The two 
identical polypeptides comprising native IYD assembly are indicated in green and cyan. 
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     In this chapter we show that the residues equivalent to Glu-153, Tyr-157, Lys-178 and 
Thr-235 of mmIYD accurately identify deiodinase enzymes. The presence of IYD enzymes 
is more pervasive thoughout the tree of life than initially thought and includes diverse 
organisms across metazoa as well as prokaryotes not initially associated with the need for 
iodine conservation. 
  
2.2 Experimental Procedures 
2.2.1 Materials 
     E. coli expression optimized genes for homologous IYDs were synthesized by Blue 
Heron Biotechnology (Bothell, WA). The pSMT3 plasmid and the SUMO specific protease 
Ulp1 expression plasmid (pET28b-Ulp1)32 were kindly provided by Dr. C. Lima 
(Memorial Sloan-Kettering Institute, New York, NY). The BluB enzyme was kindly 
provided by Dr. M. E. Taga (UC Berkeley, Berkeley, CA). The SsuE enzyme was kindly 
provided by Dr. H. R. Ellis (Auburn University, Auburn, Alabama). Expression plasmids 
(pET28) encoding IYD homologs from Streptomyces sp. HPH0547 (stIYD), Vibrio 
Harveyi CAIM 1792 (vhIYD) and Thermotoga neapolitana (tnIYD) were provided by Dr. 
Janine Copp (University of British Columbia, Vancouver). All DNA primers were 
synthesized by IDT (Coralville, IA). The pET24a plasmid and the Rosetta 2 DE3 E.coli 
cells were obtained from Novagen (Darmstadt, Germany). Phusion high fidelity DNA 
polymerase and its buffer, PageRuler broad range unstained protein standards, GeneRuler 
1Kb plus DNA standards, Genejet plasmid miniprep kit, gel extraction kit, His-Pur Ni-
NTA resin and ScintiSafe Plus 50% scintillation cocktail were obtained from Thermo-
Fisher Scientific (Waltham, MA). All restriction endonuclease enzymes were obtained 
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from NEB (Ipswich, MA). T4 DNA ligase was obtained from either NEB or Promega 
(Madison, WI). Genehogs electro-competent E. coli cells were obtained from Invitrogen 
(Carlsbad, CA). The Sephacryl S-200 HR resin for size exclusion chromatography (SEC) 
was obtained from GE Healthcare (Piscataway, NJ).  
2.2.2 General methods 
     Plasmids were purified from cultures of single colonies of E. coli cells using the Genejet 
plasmid miniprep kit. All DNA PCR reactions were performed using an Eppendorf 
Mastercycler gradient (Hauppauge, NY). All restriction digestions for PCR products as 
well as plasmids were performed at 37 °C for 1 to 2 hrs. PCR products and linearized 
plasmids were purified and visualized through agarose gel electrophoresis performed at 
100 V. DNA was extracted from agarose gels using the Genejet gel extraction kit. All 
ligation reactions were performed with T4 DNA ligase. Transformation of E. coli with 
desired plasmids was performed using the Eppendorf Eporator at 2500 V. 
     Protein purification was performed on an AKTA Prime FPLC instrument (GE 
Healthcare) for both Ni2+ affinity chromatography (1 ml/min) and size exclusion 
chromatography (SEC, 0.3-0.4 ml/min). Purified proteins were concentrated using an 
Amicon Ultra 15 centrifugal filter with a 10,000 molecular weight cut off (Millipore). 
Proteins were analyzed by SDS-PAGE at 195 V using 12% resolving and 5% stacking 
acrylamide layers. The ε280 used for protein concentration, theroretical pI and molecular 
weights of expressed IYD homologs were determined from their amino acid sequences by 
ExPASy ProtParam.43 All UV-visible absorption measurements were recorded with a 
Hewlett-Packard 8453 spectrophotometer. The FMN occupancy per enzyme active site 
was determined by measuring its absorbance at 450 nm (ε450 12500 M-1 cm-1)44 and the 
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concentration of protein was determined from its absorbance at 280 nm (ε280 for the 
proteins is provided in Appendix Table A1) after subtracting the contribution from FMN 
absorbance calculated using an A280 /A450 of 1.57 measured using free FMN. 
2.2.3 Identification, alignment and phylogenetic analysis of IYD homologs 
     Within metazoa, IYD homologs were identified through BLAST37 searches using the 
mmIYD sequence as query and specifying the species representing each phylum within the 
search parameters. Representative prokaryotic IYDs were selected through broader 
searches within entire domains (eubacteria and archaea). Sequence alignments of selected 
IYD homologs were performed using MUSCLE.45 Membrane spanning regions were 
predicted using TMHMM.46 Catalytic domains of IYDs (excluding N-terminal membrane 
regions and intermediate domains if any) were used for phylogenetic analysis.  
Table 2-1. Protein accession numbers for the IYD protein homologs deposited in the NCBI 
database.  
         Organism Protein accession 
Daphnia pulex (dpIYD) EFX90111.1 
Nematostella vectensis (nvIYD)  XP_001633169.1 
Hydra magnipapillata (hmIYD) XP_002164528.1 
Haliscomenobacter hydrossis DSM 1100 (hhIYD) YP_004447048.1 
Pyrococcus furiosus (pfIYD) WP_011012802.1 
 
2.2.4 Cloning of homologous IYDs 
     Expression optimized genes were synthesized with a C-terminal His6 tag followed by a 
stop codon and flanking 5’ Bam HI and 3’ XhoI restriction sites used for subcloning into 
the pSMT3 vector to create N-terminal SUMO fusions. Forward primer 5’-AATT-
AATCATATGCGTGTCCTCGAACTTGC-3’ and reverse primer 5’-AATTAAT-
CTCGAGTTAGTGATGATGATG-3’ containing NdeI and XhoI restriction sites 
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respectively (underlined)  were used to amplify the pfuIYD gene from the pfuIYD-pSMT3 
vector template using Phusion DNA polymerase as per manufacturer recommended 
protocol. The restriction sites underlined above were used to subclone the pfuIYD gene 
into the pET24a vector for expression without N-terminal SUMO fusion.  
2.2.5 Expression and purification of homologous IYDs 
         Rosetta 2(DE3) E. coli cells were transformed with the appropriate plasmid and 
single colonies were picked to inoculate a 20 ml starter culture of Luria LB media 
containing kanamycin (50 µg/ml) and chloramphenicol (34 µg/ml) followed by incubation 
at 37 °C with agitation for 13-15 hrs. The starter culture was diluted 50-fold in 1 L of Luria 
LB media and incubated with agitation at 37 °C until an OD600 of 0.6-0.8 was reached. 
Protein expression was induced by addition of IPTG under optimized conditions (Table 2-
2).  
Table 2-2. Induction conditions during expression of IYD homologs. 





dpIYD 50 16 12 
nvIYD 400   18         4 
hmIYD 20   16   12 
hhIYD 400   18   4 
pfIYDa 20 16 12-14 
stIYD 25 16 12-14 
vhIYDb 25 16 12-14 
tnIYD 25 16 12-14 
                        Expression and purification performed by aNattha Ingavat and bJamie Alley. 
 
Cells were then harvested by centrifugation, frozen in liquid nitrogen and stored at -80 °C. 
Prior to purification, cells were resuspended in lysis buffer (500 mM NaCl, 0.1 mM DTT, 
10% glycerol and 50 mM sodium phosphate, pH 8.0) and lysed by 3 passages through a 
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French press cell at a sustained pressure of 1000 psi or by 3 passages through an Emulsiflex 
C3 homogenizer (Avestin) at a pulse pressure of 15,000 psi. The lysates were centrifuged 
at 40,000 × g for 2 hrs to separate the cell debris. Initial purification of SUMO-IYD fusions 
and non-SUMO tagged proteins was performed using Ni2+ affinity chromatography. The 
supernatant (40 to 60 ml) was loaded on HisPur Ni-NTA column (5 ml) pre equilibrated 
with lysis buffer and subsequently washed with 5 column volumes of lysis buffer 
containing 20 mM and 60 mM imidazole and 2 to 3 column volumes of lysis buffer 
containing 100 mM imidazole. The proteins were eluted with lysis buffer containing 250 
mM imidazole. Purified SUMO-IYD fusions in elution buffer were treated with Ulp1 
(approximately 1:200 w/w) for 12 hrs.  
       The bacterial hhIYD was separated from SUMO by using a second Ni2+ affinity 
column (Hi-trap, 1 ml, GE Healthcare). Protein was dialyzed with lysis buffer to remove 
imidazole prior second Ni2+ affinity purification. After loading, column was washed with 
10 ml of lysis buffer containing 20 mM and 60 mM imidazole followed by 5 ml of lysis 
buffer containing 100 mM imidazole. The protein was eluted with lysis buffer containing 
250 mM imidazole. Fractions were analyzed by SDS-PAGE and SUMO containing 
fractions were excluded.  
     Homologs dpIYD, nvIYD and hmIYD were concentrated to 1-1.5 ml and further 
purified by SEC (200-220 ml resin per column) using buffer containing with 300 mM 
NaCl, 1 mM DTT, 10% glycerol and 50 mM sodium phosphate pH 7.4. Similarly, 
homologs tnIYD and stIYD were further purified by SEC using buffer containing 100 mM 
NaCl, 0.5 mM TCEP, 15% glycerol and 50 mM sodium phosphate pH 7.4. A third 
purification step using a Hi-trap Ni2+ affinity column as described above was necessary for 
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dpIYD. The amino acid sequence of the active dpIYD fragment was confirmed by N-
terminal protein sequencing (JHMI core facility). The pfuIYD homolog was expressed 
without the SUMO tag and purified by Nattha Ingavat who kindly provided the enzyme for 
activity analysis. The vhIYD homolog was expressed, purified and assayed for catalytic 
activity by Jamie Alley.    
2.2.6 Analysis of hmIYD 
         The presence of hmIYD in protein isolates previously assayed for deiodinase activity 
was confirmed by western blotting using an anti-His6 mouse monoclonal primary antibody 
(Novagen) and a goat anti-mouse secondary antibody conjugated to alkaline phosphatase 
(AP, Novagen). Development of the western blot was performed using the AP detection 
reagent kit (Novagen) as per the manufacturer’s recommended protocol. The total protein 
concentration was determined by a BCA assay as per the manufacturer’s protocol and the 
percentage of hmIYD was estimated by densitometric evaluation (ImageQuant TL, GE 
Healthcare) of an SDS-PAGE protein gel visualized by coomassie staining. The 
concentration of hmIYD was estimated from the observed average molecular weight of 
33.5 kDa (See results).           
2.2.7 Deiodinase activity assays 
         The deiodination rate of radiolabeled [125I]-I2-Tyr was determined by quantifying 
release of [125I]-iodide as previously described.23,36 Briefly, assay mixtures contained 200 
mM KCl, 50 mM 2-mercaptoethanol, 0.05 mM methimazole, 0.033 mM FMN and 100 
mM potassium phosphate pH 7.4 (unless specified otherwise). The total I2-Tyr and enzyme 
concentrations was optimized for each homolog. Each reaction tube contained radiolabeled 
substrate [125I]-I2-Tyr (15,000 – 20,000 cpm). Enzyme reactions were initiated by addition 
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of 10% sodium dithionite dissolved in 5% aqueous sodium bicarbonate (100 µl) to a final 
volume of 1 ml and incubated at 25 °C unless specified otherwise. Reactions were 
quenched by addition of 0.1% I2-Tyr in 0.1 N sodium hydroxide (100 µl). An aliquot from 
each reaction mixture (250 µl) was transferred to a scintillation vial containing 4.75 ml of 
10% acetic acid (S). The remaining reaction mixture (850 µl) was loaded onto AG 50W-
X8 cation exchange resin (Bio-Rad) pre-equilibrated with 10% acetic acid. The eluate was 
collected in scintillation vials and additional 10% acetic acid (4.15 ml) was added to resin 
and collected in same vial (A). The resin was further washed with 10% acetic acid (5 ml) 
and eluate was collected in a new scintillation vial (B). Scintillation cocktail (12-15 ml) 
was added to samples S, A and B and the radioactivity (cpm) in each sample was quantified 
using a Tri-Carb 2910TR scintillation counter (Perkin Elmer). The fraction of radioactivity 
released was determined from equation 2-1. The initial rate (V) is determined from 
equation 2-2 where F0 represents the background radioactivity from a control reaction 
performed without addition of enzyme. The Km and Vmax parameters for each IYD homolog 
were determined by fitting the initial rate (nmol hr-1) against substrate concentration [S] 






                                                                                              Equation 2 − 1 
 
V = (F − F0) × (2 ×
60 (mins hr−1)
Time (mins)





                                                                                                         Equation 2 − 3 
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2.2.8 BluB activity assay 
     BluB was tested for native activity using the FMN depletion assay as previously 
described in the presence of an FMN reductase enzyme, SsuE and NADPH.47 The depletion 
of added FMN substrate was monitored at 445 nm. FMN depletion was confirmed in the 
presence of BluB (Appendix, Fig. A1) 
 
2.3 Results  
2.3.1 Selection and sequence analysis of IYD homologs 
         We identified sequences homologous to mmIYD within the nitro-FMN reductase 
superfamily from a wide range of organisms representing diverse phyla within the animal 
kingdom as well as multiple prokaryotic IYD homologs from eubacteria as well as archaea. 
Many putative IYDs within the animal kingdom were annotated as such, however a few 
homologs from invertebrates lacked annotation. Prokaryotic IYD homologs from bacteria 
were mostly annotated as nitroreductases or sometimes more generally as oxidoreductases. 
IYD homologs from thermophilic archaea and bacteria were annotated as NADH oxidases.  
 
 
Figure 2-2. The tree of life indicating the diversity of organisms from which IYD 
homologs were chosen for expression. Phylum and class were obtained from the NCBI 
taxonomy browser.48 Branches are not drawn to scale. 
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IYD homologs were selected from organisms representing distinct phyla within the animal 
kingdom as well as bacterial and archaeal representatives (Fig. 2-2). Organisms widely 
studied as genetic models were chosen whenever possible. IYD homologs from some lower 
eukaryotes and prokaryotes lacked predicted membrane anchors while the archaeal IYD 
homolog completely lacked the intermediate domain in addition to the membrane anchor.  
 
 
Figure 2-3. Multiple sequence alignment of catalytic domains of representative IYD 
homologs from selected phyla within the Metazoa kingdom and Prokaryota group. 
Numbering of amino acid residues is indicated on the left and right of the alignment. 
Residues in red (or white) are fully conserved. Substrate and FMN coordination residues 
are indicated with (*) and (+) respectively.28  Columns highlighted in red indicate substrate 
zwitterion coordination residues. The column highlighted in blue indicates the residue that 
coordinates with substrate phenolate through a backbone amide and the column highlighted 




All selected homologs showed conservation of the active site lid residues that are 
characteristic of the IYD subgroup within the superfamily and Thr interacting with FMN 
cofactor. All the homologs except pfIYD showed conservation of the Ala interacting with 
substrate phenolate group through amide backbone (Fig. 2-3). 
2.3.2 Selection of diverse prokaryotic IYD homologs 
     The entire Nitro-FMN reductase superfamily of proteins was analyzed by Dr. Akiva 
(Dr. Babbit Lab, University of California at San Francisco) using Cytoscape49 to generate 
sequence similarity networks (SSN).50  
                   
Figure 2-4. Cytoscape analysis of the IYD subgroup within the nitro-FMN reductase 
superfamily using a stringency threshold value of e-70. Homologs mmIYD and hhIYD are 
indicated in brown and cyan respectively while stIYD, tnIYD and vhIYD are indicated in 




Within the superfamily, the proteins belonging to the cluster of IYD enzymes were further 
analyzed by Dr. Janine Copp (University of British Columbia, Vancouver) (Fig. 2-4). 
Genes for prokaryotic IYD homologs from Streptomyces sp. HPH0547 (stIYD, Uniprot 
S3BWA0), Vibrio harveyi CAIM 1792 (vhIYD, Uniprot M7QQY2) and Thermotoga 
neapolitana (tnIYD, Uniprot B9K712) belonging to different sub-clusters within the IYD 
cluster were provided by Dr. Janine Copp for characterization of deiodinase activity. 
Active site residues and Thr interacting with FMN are also conserved in these prokaryotic 
IYD homologs (Fig. 2-5)       
 
 
Figure 2-5. Multiple sequence alignment of catalytic domains from prokaryotic IYD 
homologs chosen for analysis of catalytic activity. Numbering of amino acid residues is 
indicated on the left and right of the alignment. Residues in red (or white) are fully 
conserved. Conserved residues thought to be diagnostic of IYD activity are indicated with 
(*). Columns highlighted in red indicate residues that coordinate the substrate zwitterion 
and the column highlighted in yellow indicates residue interacting with O4 and N5 positions 
of FMN.  
   
2.3.3 Expression and purification of IYD homologs 
     All selected proteins were initially expressed as N-terminal SUMO fusions to enhance 
their solubility. Final yields of nvIYD and hhIYD ranged from 3 to 5 mg/L. Expression of 
dpIYD and hmIYD resulted in most of the protein being sequestered in inclusion bodies 
with yields lower than 1 mg/L. N-terminal sequencing of the protein isolated from dpIYD 
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purification revealed an N-terminus with sequence had been truncated in situ by 55 amino 
acids from the N-terminus (Appendix Fig. A2 and Fig. A3). Multiple proteins were 
captured from the soluble fraction of SUMO-hmIYD after Ni2+ affinity chromatography. 
SUMO-hmIYD was only partially processed by the SUMO specific protease Ulp1 (ca. 
55%) indicating that the protein may be misfolded. Ni2+ affinity purification of SUMO-
hmIYD was repeated and the proteins captured were further purified by SEC without Ulp1 
digestion. The catalytically active fraction isolated by SEC consisted of multiple proteins 
some of which were derived from SUMO-hmIYD as determined by western blotting and 
coomassie staining (Appendix Fig. A4). A truncated SUMO-hmIYD (32 to 35 kD bands 
in western blot) comprising ca. 15% of all proteins detected in the catalytically active 
fraction was likely responsible for deiodination activity since full length SUMO-hmIYD 
(ca. 55 kDa, band in western blot) isolated separately in another SEC fraction did not 
display deiodinase activity. The sequence for hmIYD has since been revised in the NCBI 
database and differs from the expressed sequence in the first 42 amino acids which are part 
of the intermediate domain. This could explain the difficulties in expression of hmIYD.  
     The archaeal pfIYD homolog was initially expressed as a SUMO fusion protein. 
However, incomplete processing of the SUMO-pfIYD fusion following Ulp1 treatment 
indicated likely misfolding of the SUMO fusion protein. Subsequently, pfIYD was 
expressed without the SUMO tag and further purified by Nattha Ingavat to a final yield of 
about 7 mg/L. Other prokaryotic IYDs received from our collaborator Dr. Janine Copp 
were also expressed without SUMO tag. The protein yields of stIYD and tnIYD were high 




     All IYD homologs except hmIYD were purified to homogeneity (Figure 2-6). IYD 
homologs used for activity analysis contained FMN at occupancy greater than 87% other 
than nvIYD, hmIYD and vhIYD that had lower FMN occupancies of 55%, 59% and 63% 
respectively.  
 
Figure 2-6. SDS-PAGE gel images of purified IYD homologs. IYD homologs from 
daphnia (dpIYD), sea anemone (nvIYD), H. hydrossis (hhIYD) and hydra (hmIYD) are 
shown in (A). Catalytically active fraction of hmIYD is indicated with brackets. IYD 
homologs from Streptomyces Sp. HPH 0547, V. harveyi (vhIYD), T. neapolitana and P. 
furiosus (pfIYD) are indicated in (B). M is marker lane with molecular weights of protein 
markers indicated on the left in kDa. 
                       
2.3.4 Deiodination activity of IYD homologs 
     All IYD homologs selected for catalytic activity analysis displayed the ability to 
turnover I2-Tyr. Their kcat/Km values ranged between 0.12 min-1 µM-1 to 3.5 min-1 µM-1 
(Table 2-3). The Km values ranged between 1 µM and 105 µM while the kcat values ranged 
0.4 min-1 to 32 min-1. The sea anemone homolog displayed the highest kcat and Km values 
while the highest catalytic efficiencies were displayed by hmIYD and the thermophilic 
pfIYD (at 60 °C). IYD homolog tnIYD displayed lowest kcat of 0.45 min-1 that consequently 
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resulted in the lowest kcat/Km. Catalytic activity of pfIYD was assayed at pH 6.8 since the 
protein was prone to precipitation at pH 7.4. This insolubility at pH 7.4 was thought to be 
due to proximity to the theoretical pI of 7.8 as estimated by ExPASy ProtParam.43  
     The closest structural relative of IYD within the superfamily (BluB) with an alternative 
FMN destructase activity did not exhibit any deiodinase activity above the detection limit 
with Km  ≥133 µM and kcat ≤ 0.06 min-1 and a kcat/Km  ≤5 × 10-4 min-1 µM-1. No BluB-like 
activity has been previously reported when reduced mmIYD is exposed to BluB’s co-
substrate, molecular oxygen.19 In addition to lack of BluB-like activity, there is no 
precedence for IYD exhibiting catalytic activity similar to other members of the 
superfamily represented by FRP and NOX that can directly accept electrons from reduced 
nicotinamides.25 
Table 2-3. Catalytic deiodination by IYD homologs. 
Homolog Temp (° C) 
Km  
(µM) 
  kcat  
(min)-1 
kcat/Km 
 (min-1 µM-1) 
Human (hsIYD)a 25 31 ± 6     12.5 ± 1 0.40 ± 0.05 
Mouse (mmIYD)b 25 19 ± 3 6.9 ± 1.3 0.36 ± 0.09 
Zebrafish (drIYD)c 25   8 ± 1 4.1 ± 0.2 0.51 ± 0.07 
Lancelet (bfIYD)c 25   6 ± 3 7 ± 1 1.2 ± 0.6 
Honeybee (amIYD)c 25 29 ± 7  8 ± 1 0.28 ± 0.07 
Daphnia (dpIYD)d 25   7 ± 1 17.5 ± 0.8 2.5 ± 0.4 
Sea anemone (nvIYD)d 25 105 ± 26 32 ± 4 0.30 ± 0.08 
Hydra (hmIYD)d 25   4 ± 1 14 ± 1 3.5 ± 0.9 
H. hydrossis (hhIYD)d 25   6.6 ± 0.9   5.4 ± 0.3 0.8 ± 0.1 
Streptomyces Sp. (stIYD)d 25   7 ± 2   3.2 ± 0.3 0.5 ± 0.1 
V. harveyi (vhIYD)d,e 25 11 ± 3 15 ± 1 1.4 ± 0.4 
P. furiosus pfIYDd,f 25   1.0 ± 0.1   0.442 ± 0.008 0.4 ± 0.1 
P. furiosus pfIYDd,f 60   1.8 ± 0.3   5.5 ± 0.2 3.1 ± 0.5 
T. neapolitana (tnIYD)d 25 - < 0.4 - 
T. neapolitana (tnIYD)d 60 3.8 ± 0.7 0.45 ± 0.02 0.12 ± 0.02 
a-c Parameters were previously reported.29-31 dDetermined from data illustrated in Appendix Fig. A5. 
Errors derive from least square fitting. eAssay performed by Jamie Alley. fEnzyme assays 




     All IYD homologs from eukaryotes exhibited deiodination activity with catalytic 
efficiencies distributed within an order of magnitude. Amongst the prokaryotic IYD 
homologs evaluated, all displayed deiodination rates within an order of magnitude with the 
exception of tnIYD that displays about 25 to 30-fold lower catalytic efficiency than the 
most efficient deiodinases. However, the catalytic efficiency of tnIYD is still within an 
order of magnitude of the average catalytic efficiency displayed by other enzymes. 
Increased kcat at 60 °C compared to 25 °C is expected for IYD homologs from thermophilic 
(T. neapolitana) or hyperthermophilic (P. furiosus) organisms.  
     The key residues selected from the crystal structure of mmIYD (Glu-153, Tyr-157, Lys-
178 and Thr-235) are indeed excellent predictors of deiodinase activity despite the large 
variations in sequence length (including gaps in the active site loop regions of prokaryotic 
thermophilic IYDs) and identity (Figs. 2-2 and 2-4) . We had initially included the Ala-126 
(blue highlight Fig. 2-2) providing the backbone hydrogen bonding interaction as a key 
identifier of IYD. However, expanding our BLAST search with lower stringencies (expect 
values >10-40) identified homologous proteins from thermophilic prokaryotes wherein the 
Ala-126 was replaced by a Met at the equivalent position. IYD homologs pfIYD and 
tnIYD, both having this Met residue instead of an Ala display deiodinase activity. Since 
this residue provides a backbone amide hydrogen bonding interaction to the phenolate of 
substrate, lack of conservation is not surprising since this interaction could still be 
maintained by another amino acid. 
     The phylogenetic analysis of amino acid sequences of IYD homologs, nitro-FMN 
reductases (FRP and NOX) and BluB (Fig. 2-5) indicates the divergent evolution of 
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representatives within this superfamily. Clearly, the thermophilic prokaryotic IYDs are 
most distant from IYDs of higher organisms and are more likely to exhibit some 
promiscuity. This may explain the relatively low kcat and kcat/Km exhibited by tnIYD. 
Despite low sequence identity (19%), BluB and IYD share significant similarities with 
their active site lids derived from the same region of their primary structure.28,33 The FMN 
cofactor in both BluB and IYD is primed for sequential one electron chemistry.13,31 Inspite 
of these similarities, BluB does not catalyze deiodination of I2-Tyr above our limits of 
detection.      
                      
Figure 2-7. Phylogenetic analysis of the IYD subgroup proteins and other representatives 
of the nitro-FMN reductase superfamily. This phylogenetic tree was generated by 
phylogeny.fr through integration of MUSCLE,45 PhyML,51 and TreeDyn52 for multiple 
sequence alignment, phylogenetic analysis and tree rendering respectively. Catalytic 
domains of IYD homologs and aligned regions of BluB (PDB ID 2ISJ), NOX (PDB ID 
1NOX) and FRP (PDB ID 2BKJ) were used as input sequences. The branch lengths are 
proportional to the number of amino acid substitutions per aligned residue. 
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     The presence of IYD was expected within chordata (Fig. 2-2) as organisms within this 
group have a thyroid gland or an endostyle and likely produce THs requiring salvage of 
iodide. The presence of this enzyme within arthropods represented by insects and 
crustaceans is surprising and very intriguing since there is no confirmed evidence for 
endogenous TH production53 although some reports suggest that these may be obtained 
from external sources53,54 and affect insect metabolism.55-57 The requirement for iodine 
recycling and role of iodotyrosines in insects still remains elusive. Within Cnidaria, the 
role of IYD in hydra and sea anemone is unknown and no reports were found regarding 
effects of iodide, iodotyrosines or THs in these organisms. Amongst other cnidarians, the 
above mentioned compounds were shown to be capable of initiating strobilation 
(metamorphosis from polyp to medusa) of the jellyfish Aurelia aurita.58 I2-Tyr was shown 
to be the most potent stimulator of this change indicating that iodotyrosines could be 
evolutionary precursors of the THs as proposed previously.38 In this case, IYD could be 
functioning in a regulatory capacity.      
     A regulatory or iodide salvage role cannot be ascribed to IYD homologs from 
prokaryotes although some bacterial strains have been shown to accumulate iodine.59,60 
The enzyme is likely involved in catabolism or detoxification enabling bacterial and 
archaeal species to adapt to environments containing iodinated compounds. In addition, 
chlorinated and brominated compounds might also be substrates for these prokaryotic IYDs 
since at least mmIYD has already been shown to dehalogenate bromo- and 
chlorotyrosine.19  
     No IYD homolog has been identified within fungi. BLAST search for IYD homologs 
in fungi yielded proteins with weak homology not showing conservation of any of the 
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signature residues previously described. Even the fungi Neurospora crassa that encodes 
several metabolic flavoproteins61 did not contain an IYD gene. Plant proteins showed very 
poor homology to members from the nitro-FMN reductase superfamily.  
 
2.5 Summary 
      The residues Glu-153, Tyr-157, Lys-178 coordinating the substrate zwitterion and 
residue Thr-235 coordinating the O4 and N5 of FMN cofactor as identified from the crystal 
structure of mmIYD are excellent predictors of deiodinase activity. IYD homologs from a 
diverse range of organisms ranging from prokaryotes (bacteria and archaea) to 
representatives of several phyla within metazoa displayed deiodinase activity in vitro with 
catalytic efficiencies ranging from 3.5 min-1 uM-1 to 0.12 min-1 uM-1. Sequence identity 
between the most distant IYD homologs (mmIYD and tnIYD) was just 37% however, all 
the aforementioned residues were conserved. Our results should facilitate functional 
assignments for putative IYDs within the nitro-FMN reductase superfamily. The presence 
of IYD is more widespread than initially thought based on its known function of iodide 
salvage in the thyroid gland of mammals. Catalytically competent IYDs have also been 
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Chapter 3: Functional analysis of the Drosophila halotyrosine dehalogenase 
3.1 Introduction 
     IYD is primarily associated with iodine salvage from I-Tyr and I2-Tyr, the byproducts 
of TH synthesis.13 Surprisingly, we identified functional IYDs even in non-chordate 
invertebrates such as arthropods (insects and crustaceans) and cnidarians (radially 
symmetrical lower invertebrates such as anemones and jelly fish) that lack a thyroid gland 
or endostyle and no conclusive evidence for endogenous TH synthesis by these organisms 
has been reported (Chapter 2).          
     Previously, IYD has also been shown to promote dehalogenation of Br-Tyr and Cl-Tyr 
in addition to I-Tyr in single turnover experiments.19,62 As an iodine requirement for 
thyroid hormone synthesis is unlikely in non-chordates, the primary substrates for their 
IYDs could be other halotyrosines like Br-Tyr and Cl-Tyr. Halogenated tyrosines have 
been reported in scleroproteins of insects63 and their formation would not be surprising 
since Tyr plays a primary role in formation of cross-linked proteins.64 IYD within insects 
could potentially serve as a general halotyrosine dehalogenase enzyme or may exhibit a 
particular halotyrosine preference characteristic of its physiological substrate. 
     Previously, the IYD homolog from Apis mellifera (honeybee) was selected as the insect 
representative for expression and deiodinase activity testing30 rather than from Drosophila 
melanogaster, an insect model organism used extensively to probe gene function, since the 
Drosophila IYD homolog showed the presence of a large N-terminal domain of unknown 
function in addition to the deiodinase domain. However, the deiodinase domain shows high 
conservation of all residues now shown to be robust predictors of IYD activity, including 
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Glu, Tyr and Lys interacting with the substrate and Thr interacting with the FMN cofactor 
(Fig. 3-1).  
 
Figure 3-1. Multiple sequence alignment of catalytic regions of mouse and Drosophila 
IYD. Sequence alignment was performed using MUSCLE.45 Numbering of amino acid 
residues is indicated on the left and right of the alignment. Conserved residues diagnostic 
of IYD activity are indicated in white.  
 
In addition, alternative splicing of the IYD encoding gene annotated as CG6279 in the 
FlyBase is predicted to generate isoform B that lacks the additional N-terminal domain 
entirely (Appendix Fig. B1).65 Isoform B of Drosophila IYD lacking membrane anchor 
(dmIYD) is therefore an ideal choice for detailed in vitro studies of an IYD homolog from 
a model non-chordate invertebrate species wherein the biological role of this enzyme is not 
yet known.  
     In this chapter, we examine the preferred halotyrosine substrate for dmIYD through the 
measurement of equilibrium binding and steady-state kinetics of turnover of I-Tyr, Br-Tyr 
Cl-Tyr and F-Tyr. In order to determine the relative importance of evolutionarily conserved 
active site Glu, Tyr and Lys residues coordinating the zwitterion of substrate, we expressed 





3.2 Experimental Procedures 
3.2.1 Materials 
     Pfu Turbo DNA polymerase and its buffer were obtained from Agilent (Santa Clara, 
CA).  3-Bromo-L-tyrosine (95% pure) was purchased from AEchem Scientific Corporation 
(Naperville, IL). 3-Fluoro-L-tyrosine (97% pure) was purchased from Astatech Inc 
(Bristol, PA). 3-Iodo-L-tyrosine (97% pure) and 3, 5-diiodo-L-tyrosine (97% pure) were 
purchased from Acros Organics and Sigma respectively. Other materials used are as 
described in chapter 2 (2.2.1). 
3.2.2 Cloning of dmIYD 
     IYD homolog from Drosophila melanogaster (isoform B, Accession NP_001163414.1, 
Flybase CG6279-PB) was truncated to remove an N-terminal transmembrane domain 
(amino acids 2-40) predicted by TMHMM.46 This truncated gene sequence is designated 
as dmIYD. Codon optimized gene sequence for E. coli expression including a His6 tag and 
stop codon at C-terminus was synthesized by Blue Heron Biotechnology (Appendix Fig. 
B2) and subcloned to generate N-terminal SUMO fusions in the pSMT332 plasmid. 
Forward primer 5’-AAACAAACATATGAAAACTTATAATTTAGATGAAC-3’ and 
reverse primer 5’-AATTAATCTCGAGTTAGTGGTGATGGT-3’containing NdeI and 
XhoI restriction sites respectively (underlined) were used to amplify and subclone the 
dmIYD gene into the pET24a vector for subsequent expression without the SUMO tag. 
3.2.3 Site-directed mutagenesis of dmIYD 
     The pET24a-dmIYD vector was employed as the template for site-directed mutagenesis 
using the Pfu turbo DNA polymerase. Primer 5’-GTAGAACAAGAACAGTTAG-
TCAATTAC-3’ and its reverse complement were used to generate the E154Q mutation. 
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The Y158F mutation was introduced by the primer 5’-AAATTGTAGAACAAGAAG-
AATTAGTCAATTTCTCCCAACGTATGCAT-3’ and its reverse complement while the 
K179Q mutation was introduced using primers 5’-ACCAATCATGTACAGGA-
ATACTTAACC-3’ and its reverse complement. The mutated codon is indicated in red. 
Thermocycling conditions for site-directed mutagenesis were performed as recommended 
by the Quikchange protocol (Agilent). Proper amplification of the mutation containing 
plasmids was confirmed by 1% agarose gel electrophoresis prior to their transformation 
into electro-competent Genehogs E. coli cells (Invitrogen). Plasmids were purified from 
cultures of single colonies and introduction of the mutations was confirmed by DNA 
sequencing (Genewiz). 
3.2.4 Expression and purification of dmIYD enzymes 
     For protein expression, the appropriate plasmid was transformed into Rosetta 2 (DE3) 
E. coli cells (Novagen). All other expression conditions were similar to those described in 
chapter 2 (2.2.5) with the exception that 25 mM imidazole was added to the lysis buffer. 
Purification of dmIYD expressed without SUMO tag was performed as described for stIYD 
and tnIYD proteins in chapter 2 (2.2.5). 
3.2.5 Binding affinity determination 
     The binding affinity of dmIYD and its derivatives was determined by fluorescence 
quenching of the protein-bound FMN cofactor (λex of 450 nm and λem of 520 nm) upon 
addition of ligands as previously described.19,31 Fluorescence intensity was measured using 
a Fluoromax-4 fluorescence spectrophotometer (Horiba Scientific). Protein solutions were 
prepared in buffer containing 200 mM potassium chloride and 100 mM potassium 
phosphate pH 7.4 to a final concentration of 3 µM enzyme as measured by associated FMN 
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(ε450 12,500 M-1 cm-1).44 Observed fluorescence signal (F) was normalized through division 
by the initial fluorescence signal (no ligand added, F0) and plotted against added ligand 
concentration (S). Equilibrium dissociation constant (Kd) values were determined by non-
linear least squares fitting of the data to equation 347,66 using Origin 6.0. F is the observed 
fluorescence signal, F0 is the initial fluorescence signal in absence of ligand, ΔF represents 







(Kd + Et +  S) −  √(Kd + Et + S)2 − 4 EtS
2Et
)                  Equation 3 
3.2.6 Catalytic activity assay with 125I-[I2-Tyr] 
     The deiodination of radiolabeled 125I-[I2-Tyr] was performed as described in chapter 2 
(2.2.7) to measure catalytic activity of dmIYD and its mutants.  
3.2.7 Kinetics of monohalotyrosine turnover by dmIYD 
     Catalytic dehalogenation of 3-halotyrosines was measured by quantifying the Tyr 
produced in the presence of enzyme by reverse phase HPLC using an Agilent 1100 series 
instrumental setup. The reaction buffer comprised of 200 mM KCl and 100 mM potassium 
phosphate pH 7.4. The internal standard (IS) included was m-cresol (30 µM). Reaction was 
initiated by addition of 5% sodium dithionite in 5% sodium bicarbonate (100 µl) to a final 
reaction volume of 1 ml with incubation at 25 °C. Reaction was quenched by addition of 
88% formic acid (50 µl) and the entire mixture was injected onto a Microsorb MV 300-5 
C18 analytical column (Varian) connected to a manually packed C18 silica guard column. 
The solvent system comprised of 0.44% aqueous formic acid (A) and 0.44% formic acid 
in acetonitrile (B). Analytes were separated using a linear gradient from 0% B to 5% B 
over 10 mins and 5% B to 60% B over the next 15 mins. A brief linear drop from 60% B 
to 30% B was added over the next 2 mins to prevent drifting of the baseline that could 
35 
 
affect the internal standard peak. The column was washed with 95% B and re-equilibrated 
with 100% A prior to the next injection. All analytes were detected at 280 nm. The 
concentration of Tyr produced by dmIYD was be determined from a standard curve 
generated by spiking known concentrations of Tyr into reaction mixtures lacking the 
halotyrosine substrate. The ratio of the areas of Tyr signal to IS signal was plotted against 
the concentration of Tyr spiked into the reaction and the equation of the line was 
determined by linear regression (Appendix Fig. B3). This equation was used to determine 
the concentration of Tyr produced during enzymatic reactions. The kinetic parameters were 
determined by fitting the data to the Michaelis-Menten equation as previously described in 
chapter 2 (2.2.7). Br-Tyr contained Tyr as an impurity and the contribution of the Tyr 
impurity was subtracted from the product signal prior to data analysis based on the standard 
curve (Appendix Fig. B4). The Tyr impurity in commercially purchased Br-Tyr was 
determined to be 5 % molar equivalents.  
 
3.3 Results  
3.3.1 Expression and purification of dmIYD proteins 
     Similar to other IYD homologs, dmIYD was initially expressed as a SUMO fusion 
followed by cleavage of SUMO by its selective protease Ulp1 and separation of SUMO by 
SEC. This process provided relatively low protein yields of 4 to 7 mg/L. Subsequently, 
dmIYD was expressed in E. coli without the SUMO fusion to streamline purification and 
generate high yields of 8-11 mg/L. All dmIYD mutants were also expressed without a 
SUMO fusion in yields between 5-12 mg/L (Fig. 3-2). FMN occupancy in dmIYD and its 
mutants was relatively consistent between 82 to 90%. 
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Figure 3-2. SDS-PAGE gel image of purified dmIYD and mutant proteins (~7.5 µg per 
well). M is marker lane with molecular weights of protein markers indicated on the right 
in kDa. 
 
3.3.2 Substrate specificity of dmIYD. 
     The biological function of IYD in non-chordates has not been established and therefore 
the natural substrate for dmIYD could be a halotyrosine other than I-Tyr. To determine the 
specificity of dmIYD, the binding affinity and the kinetic parameters of steady-state 
turnover for each halotyrosine was measured. The enzyme exhibited little discrimination 
between I-Tyr, Br-Tyr and Cl-Tyr with Kd values lower than 1 µM (Fig. 3-3, Table 3-1). 
However, binding affinity of F-Tyr was significantly lower (25-fold) than that for other 
halotyrosines.  
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Figure 3-3. Quenching of FMN fluorescence is indicative of ligand binding in the active 
site of dmIYD. Each data point for I-Tyr, Br-Tyr and Cl-Tyr binding represents an average 
of 3 individual observations and error bars represents its standard deviation. F-Tyr binding 
curve is represented by a single data set. The Kd values are derived from the best fit of the 
data (solid lines) to equation 3. 
 
     The dehalogenation product (Tyr) from turnover by dmIYD was detected and quantified 
by HPLC (Figure 3-4, Appendix Fig. B5). The Km was lowest for Br-Tyr and highest for 
Cl-Tyr while kcat was highest for I-Tyr and lowest for Cl-Tyr (Table 3-1). Overall, catalytic 
efficiency of I-Tyr and Br-Tyr turnover was similar while turnover of Cl-Tyr was about 
3.5-fold less efficient. We did not detect any Tyr formation above the limit of detection 
when F-Tyr was used as a substrate for dmIYD even in presence of 25-fold higher enzyme 







               
Figure 3-4. Detection of tyrosine after halotyrosine turnover by dmIYD using reverse 
phase HPLC. (A) I-Tyr (40 µM) was incubated with dmIYD (0.08 µM) for 20 mins. (B) 
Br-Tyr (40 µM) incubated with dmIYD (0.12 µM) for 20 mins. (C) Cl-Tyr (40 µM) 
incubated with dmIYD (0.2 µM) for 20 mins. Internal standard was m-cresol. For complete 

























I-Tyr 0.62 ± 0.08 14 ± 4 7.3 ± 0.6 0.5 ± 0.2 
Br-Tyr 0.47 ± 0.06   8 ± 2 4.2 ± 0.3       0.5 ± 0.1 
Cl-Tyr 0.46 ± 0.08 21 ± 6 3.0 ± 0.3 0.14 ± 0.04 
F-Tyr  17.6 ± 0.8 - <0.002 - 
aDetermined from data illustrated Figure 3-2. bDetermined from data illustrated in Appendix Fig. B6. Errors 
derive from least square fitting. 
 
3.3.3 Contribution of zwitterion coordination residues towards substrate affinity 
     Three active site residues Glu-153, Tyr-157 and Lys-178 as seen in crystal structure of 
mmIYD·I2-Tyr (Chapter 2, Fig. 2-1) coordinate the substrate zwitterion and include 3 of 
the 4 residues shown to be diagnostic of IYD activity in the previous chapter. These 
residues are likely unique to IYDs within the superfamily and critical for substrate 
recognition. Limited information regarding their relative importance was obtained 
previously from mutagenesis of the mouse IYD.29 Interest in these residues was renewed 
when IYD was found to be pervasive throughout diverse organisms. Identifying their 
relative contribution will help to define the origins of this enzyme.  
     The dmIYD enzyme exhibits strong binding affinity towards I2-Tyr with a Kd value of 
less than 1 µM. (Fig. 3-5 A, Table 3-2). Removal of the phenolic OH group coordinating 
the zwitterion by a Phe substitution (Y158F) results in a 7-fold decrease in affinity for I2-
Tyr. Replacement of the carboxylate group coordinating the zwitterion with an amide 
group (E154Q) results in a 30-fold decrease in affinity for I2-Tyr while replacing the 
charged ammonium with an amide (K179Q) is most deleterious towards binding affinity 
and results in a 45-fold decrease in affinity for I2-Tyr. While the Kd displayed by dmIYD 
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for I2-Tyr and I-Tyr is very similar, each of the mutant enzymes display a 7- to 10-fold 
lower affinity for I-Tyr compared to I2-Tyr (Fig. 3-5 B, Table 3-2). 
 
 
Figure 3-5. Quenching of FMN fluorescence is indicative of I2-Tyr (A) and I-Tyr (B) 
binding in the active site of dmIYD and its mutants. Each data point represents an average 
of 3 individual observations and error bars represent standard deviation from the averages. 
The Kd values are derived from the best fit of the data (solid lines) to equation 3. 
 
Table 3-2. Impact on substrate coordination after active site mutagenesis of dmIYD. 
 
                                     Kd (µM) 
Enzyme    I2-Tyr I-Tyr 
dmIYDa  0.54 ± 0.05    0.62 ± 0.08 
dmIYD Y158Fa    3.8 ± 0.2       42 ± 2 
dmIYD E154Qa     16 ± 0.8     112 ± 5 
dmIYD K179Qa     25 ± 1     230 ± 10 
mmIYDb          -     2 ± 0.2 
mmIYD Y157Fb -       40 ± 10 
mmIYD E153Qb -       >1000 
aDetermined from data illustrated in Fig. 3-5. Errors derive from least square fitting. bParameters were 
previously reported.29 
 
3.3.4 Contribution of zwitterion coordination residues towards catalysis 
     The catalytic efficiency of dmIYD for turnover of [125I]-I2-Tyr was within the range of 
the catalytic efficiencies of previously assayed IYD homologs (Table 2-3 and Table 3-3). 
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The Y158F mutation resulted in an 8-fold increase in Km while kcat was increased by little 
over 2-fold (Table 3-3). The overall impact on kcat/Km was a modest 3.5-fold decrease 
compared to dmIYD. The K179Q mutation resulted in a 64-fold increase in Km while kcat 
was not affected significantly. The catalytic efficiency was lowered by 55-fold compared 
to dmIYD. The E154Q mutation had a large effect on Km which increased over 300-fold 
while the kcat was modestly reduced by nearly 3-fold. The catalytic efficiency was most 
adversely affected with an 860-fold decrease compared to dmIYD.  










dmIYDa 11 ± 2   6.5 ± 0.4         0.6 ± 0.1 
dmIYD Y158Fa   90 ± 20 15 ± 2       0.17 ± 0.04 
dmIYD K179Qa     700 ± 100     7.7 ± 0.5     0.011 ± 0.002 
dmIYD E154Qa   3400 ± 500   2.4 ± 0.2   0.0007 ± 0.0001 
mmIYDb   65 ± 16   9.3 ± 1.6       0.23 ± 0.05 
mmIYD Y157Fb     440 ± 170   65 ± 16       0.15 ± 0.07 
 aDetermined from data illustrated in Appendix Fig. B8. Errors derive from least square fitting. bParameters 
were previously reported.29  
 
3.4 Discussion  
3.4.1 Possible substrates for dmIYD 
     Halotyrosines I-, Br- and Cl-Tyr are all substrates for dmIYD in vitro. The enzyme did 
not exhibit substantial preference for any of these substrates based on nearly identical 
binding affinities and similar catalytic efficiencies of dehalogenation. The kcat values 
correlate to the phenyl carbon-halogen (C-X) bond strength with the highest kcat measured 
for the weakest C-I bond and lowest kcat measured for stronger C-Cl bond. The differences 
in kcat are small compared to the differences in C-X bond strength that increases by about 
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15 kcal mol-1 each from C-I to C-Br and C-Br to C-Cl.67 The kcat/Km for steady state 
turnover of I-Tyr and Br-Tyr by dmIYD (0.5 min-1 µM-1) is similar to the second order pre-
steady state rate constants (kox) for single turnover of I-Tyr and Br-Tyr by human (hs) IYD 
(0.52 min-1 µM-1 and 0.44 min-1 µM-1).62 However, the kcat/Km for steady state turnover of 
Cl-Tyr (0.14 min-1 µM-1) by dmIYD is about 5- to 6-fold higher than kox for hsIYD (0.024 
min-1 µM-1) suggesting that Cl-Tyr is processed more rapidly by dmIYD than hsIYD. 
Consistent with earlier observations involving mammalian IYDs,19,31 F-Tyr binds 
relatively weakly to dmIYD and generates no detectable product in presence of 25-fold 
higher enzyme concentration and 6-fold longer incubation time (kcat < 0.002 min-1) than 
used for other halotyrosines precludes it as a substrate. This is not surprising since 
fluorinated tyrosine residues are not known to occur naturally68 and these enzymes have 
consequently not evolved to reduce the strong C-F bond.   
     Little information exists about function of iodine in insects. Unlike chordates, insects 
are not known to synthesize THs which require iodine. Other proteins involved in TH 
synthesis and metabolism and iodide uptake including TPO, IDs and the NIS do not have 
reported homologous counterparts in Drosophila.57 Very early studies involving feeding 
radioactive 131I isotope to Drosophila gibberosa larvae had indicated iodide accumulation 
in specific areas of the larval cuticle especially in posterior ventral regions and near air 
passages and mouth regions suggesting incorporation via specific metabolic processes.69 It 
is possible that iodotyrosines are produced by action of peroxidase enzymes during insect 
cuticle sclerotization and are substrates for dmIYD. Br-Tyr is produced by hypobromous 
acid generated through eosinophil peroxidase activity during inflammatory responses in 
mammals and has recently been observed as a substrate for IYD.70 Bromine has been 
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demonstrated to be essential for collagen crosslinking via hypobromous acid produced by 
peroxidasin activity and the complete absence of bromine in food sources can be lethal in 
Drosophila.71 Hypobromous acid may also brominate tyrosine residues and produce 
bromotyrosine for later processing by dmIYD. Chlorotyrosines have been reported in the 
sclerotized cuticle of locusts and other insects.72 It is possible that dmIYD plays a catabolic 
role by degrading the halogenated tyrosine residues produced as by-products of other 
metabolic reactions or dmIYD could be involved in processing of halotyrosines in a yet 
undiscovered function in insects and other lower invertebrates.   
 3.4.2 Relative Importance of Active Site Residues 
     The three active site residues Glu, Tyr and Lys coordinating the halotyrosine substrate 
zwitterion via their side chains are conserved in IYDs from mammals to prokaryotes 
investigated to date and are thought to be general markers for halotyrosine substrate 
recognition within the IYD subgroup of the nitro-FMN reductase superfamily. Previously, 
active site mutations had been attempted with mmIYD, but additional non-native mutations 
at cysteine residues (Cys to Ala) were necessary for bacterial expression of soluble protein. 
While limited information could be gathered for these mutants (Table 3-2 and Table 3-3), 
the catalytic efficiency could not be accurately quantified for the E153Q mutant. 
Furthermore, the K178Q mutant was insoluble and precluded further analysis.29 In contrast, 
all 3 mutations were well tolerated at equivalent residues of dmIYD and this facilitated the 
determination of their relative impact on binding affinity as well as catalysis. The active 
site E154 is most important for efficient catalysis and a conservative change of E154Q 
substituting the negative carboxylate for amide resulted in a decrease in catalytic efficiency 
by nearly 3 orders of magnitude. However, this loss in catalytic efficiency cannot be 
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entirely attributed to the loss in binding affinity as previously thought for the equivalent 
E153Q mutant of mmIYD29, since an alternative K179Q mutant of dmIYD displayed 
greater loss in binding affinity for I2-Tyr than the E154Q mutant (46- versus 30-fold) but 
maintained significantly higher (16-fold) catalytic efficiency. Both ligand affinity and 
catalysis are least affected by the Y158F mutation that eliminates hydrogen bonding 
between a phenolic OH and the substrate zwitterion. The overall impact of active site 
mutations on catalysis are likely linked to the ability of the enzyme-substrate complex to 
re-position an active site Thr to enable hydrogen bonding to the FMN N5.  The importance 
of such a substrate-dependent activation of the FMN cofactor was indicated from previous 
structural and catalytic studies of hsIYD as well as catalytic studies of prokaryotic 
hhIYD.31,73      
     Previous studies on hsIYD indicated preferential binding of the deprotonated phenolate 
form of the substrate compared to its neutral phenol form.31 Coordination of the substrate 
phenolate to both the 2’-hydroxy group of FMN and a backbone amide hydrogen as 
observed in all co-crystal structures of IYD·I-Tyr supports this observation.31,28  However, 
the Kd values of I-Tyr and I2-Tyr are not indicative of the greater proportion of the 
phenolate form of I2-Tyr (91%, pKa 6.4)74 versus I-Tyr (7%, pKa 8.5)75 under assay 
conditions (pH 7.4). Instead for hsIYD, the Kd value for I-Tyr is smaller than I2-Tyr.31 
Accommodation of the added steric bulk of an additional iodo substituent requires some 
structural changes in the active site that likely dominate the higher affinity for the 
predominantly phenolate form of I2-Tyr. In the case of dmIYD, these opposing properties 
may balance each other since the Kd values for I-Tyr and I2-Tyr are nearly indistinguishable 
(Table 2).  This balance is not maintained in the three active site mutants. Even though the 
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mutated residues most directly affect the coordination of the zwitterion that is common to 
both I-Tyr and I2-Tyr, their affinity for I-Tyr is 7- to 10-fold lower than for I2-Tyr (Table 
3-2). This is the first time the bulkier I2-Tyr substrate has exhibited a lower Kd value and 
may reflect a greater sensitivity to the significantly higher fractional population of the 
phenolate form in solution. However further evidence is required though pH profile studies 
on dmIYD and its mutants.  
     Overall, the relative impact of active site residues on substrate recognition and catalysis 
should be broadly applicable to IYD homologs within the nitro-FMN reductase 
superfamily given the high degree of conservation of these residues from archaea to 
mammals. Our findings should facilitate the annotation of enzymes within the nitro-FMN 
reductase superfamily with the active site Glu being the most robust indicator of a 
halotyrosine dehalogenase followed by Lys while Tyr is more replaceable than other active 
site residues. We identified archaeal nitro-FMN reductase superfamily members in which 
the active site Tyr is replaced with His but the requisite Glu and Lys are conserved such as 
putative NADH oxidases from Hyperthermus butylicus (Accession WP_011822328.1) and 
Staphylothermus marinus (Accession WP_011839241.1). These proteins are likely to 
function as halotyrosine dehalogenases. 
      
3.5 Summary  
     Efficient and comparable dehalogenation of I-Tyr, Br-Tyr as well as Cl-Tyr is 
demonstrated by dmIYD. These results indicate that the enzyme may function more 
broadly as a halotyrosine dehalogenase rather than just an iodotyrosine deiodinase, an 
annotation ascribed to it following the discovery of its primary function of iodine salvage 
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in the mammalian thyroid. Through site directed mutagenesis of active site residues, we 
demonstrated that Glu coordinating the substrate zwitterion is most important for catalysis 
followed by Lys. The Tyr residue has the smallest effect on the catalytic efficiency. The 
impact of mutating these active site residues on catalysis is not entirely due to loss in 
binding affinity as previously thought since the K179Q mutant actually displays weaker 
affinity for ligand than the E154Q mutant. Our results should further facilitate annotation 
of halotyrosine dehalogenases within the nitro-FMN reductase superfamily of enzymes.  















Chapter 4: Silencing the halotyrosine dehalogenase gene in Drosophila using 
RNAi 
4.1 Introduction 
The fruitfly has been studied as a genetic model organism for over a century.76,77 Its genome 
encodes approximately 15,000 genes and has more homologs to human genes than C. 
elegans, a worm model organism.78 Traditional genetic studies relied on abnormal 
phenotypes to discover gene function, an approach known as forward genetics. Since the 
Drosophila melanogaster (referred to as simply Drosophila hence forth) genome was 
sequenced in 2000,79 geneticists  began to utilize the strategy entitled reverse genetics that 
involves modifying a known gene sequence and investigating its phenotypic 
manifestations.80 Drosophila, being one of the most genetically tractable organisms 
enabled rapid development of tools for genetic investigations such as balancer 
chromosomes with multiple inversions (segments of chromosomes with reversed 
orientations), dominant phenotypic markers and recessive lethal mutations.81 
Recombination between homologous chromosomes with and without inversions is 
suppressed during meiosis.82 Drosophila strains with a chromosome carrying a lethal gene 
mutation can be maintained through pairing with a corresponding balancer chromosome  
and obviating the need to perform genetic screens for each generation.83      
     A widely used reverse genetics approach relies on gene silencing by RNA interference 
wherein the mRNA for a particular gene is degraded after recognition by double stranded 
RNA of complementary sequence.84 A heterologous yeast expression system employing 
the GAL4 transcriptional activator recognizing the upstream activating sequence (UAS) 
has been widely employed to drive expression of RNAi in Drosophila.85,86 GAL4 
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expression can be controlled by tissue and cell type specific Drosophila promoters enables 
targeted silencing of a gene of interest. Each component of this dual system (GAL4 and 
UAS) is maintained in separate parent strains (usually balanced) and is inherited by the 
offspring leading to silencing of the target gene when the selected promoter is 
endogenously expressed. GAL4 allows for modulation of gene silencing in a temperature 
dependent manner (optimal activity at 29 °C  and  minimum activity at 16-18 °C in 
Drosophila).85 
              




Figure 4-1. The GAL4-UAS system commonly used for gene silencing in Drosophila. 
GAL4 expression is controlled by a chosen species specific promoter. This figure is 
adapted from Brand and Perrimon.85 
 
     Previous genome wide profiling of the Drosophila transcriptome indicated high 
expression of the halotyrosine dehalogenase encoding gene (CG6279) in the adult male 








Figure 4-3. Germline lineage in Drosophila spermatogenesis. Development proceeds from 
the left (tip of testes) to the right as indicated in figure. Figure was provided by Dr S. Eun.89 
 
In this chapter we investigate the expression pattern of CG6279 mRNA in Drosophila 
testes through in situ hybridization. Using the reverse genetics approach we also investigate 
the effects of CG6279 gene silencing on male fertility and testes morphology. All 
experiments described in this chapter were performed in collaboration with Dr. S. Eun (X. 
Chen Laboratory, JHU Biology). 
 
4.2 Experimental Procedures 
4.2.1 Drosophila Stocks 
     Drosophila were raised on standard yeast, molasses, cornmeal and agar medium and 
maintained at 25 °C. Yellow White (yw) reference Drosophila strain and appropriately 
balanced GAL4 expression strains including nos-GAL4 (3rd chromosome); bam-GAL4, 
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eya-GAL4 (2nd chromosome), ubi-GAL4 (2nd chromosome) and UAS-dcr2 were used from 
stocks available in the laboratory of Dr X. Chen (Dept. of Biology, JHU). The RNAi 
expression strains UAS-37267 RNAi (3rd chromosome) and UAS-105378 RNAi (2nd 
chromosome) were obtained from the Vienna Drosophila RNAi center (VDRC, Vienna, 
Austria). Balanced UAS-shmiRNA-A, UAS-shmiRNA-AB and UAS-shmiRNA-B stocks were 
generated as described below. Drosophila from selected GAL4 expressing strains were 
mated with chosen UAS-RNAi strains to obtain progeny expressing interfering RNA. 
4.2.2 In situ hybridization  
RNA in situ hybridization (ISH) for detection of CG6279 transcript was performed as 
previously described.92,93 Expression pattern of CG6279 was detected using whole mount 
testes from the yw strain. Primers 5’-CATGAAGTTTCGGTAGAAGAG–3’ (forward) and 
5’– CATCTGCACTTGCTGGCTATT–3’ were used to amplify a 405 bp region of isoform 
A transcript of CG6279 (CG6279-RA) from a Drosophila testes cDNA library (kindly 
provided by Dr S. Eun, Chen lab, Dept. of Biology, JHU) by using Taq DNA polymerase 
(Thermo Scientific). Similarly, primers 5’-ATTGTGGAACAGGAGGAGCTG-3’ 
(forward) and 5’-ATTCTTTCTCGCCAAGTCGGG-3’ (reverse) were used to amplify a 
393 bp region of CG6279 that is common to both isoforms A and B of CG6279 (CG6279-
RA and CG6279-RB). The PCR products with 3’-A overhangs (added by Taq DNA 
polymerase in a non-template dependent manner) were then ligated into the linearized 
pGEM-T Easy plasmid (Promega) with 3’-T overhangs using T4 DNA ligase (Promega) 
and transformed into GeneHogs E. coli cells (Invitrogen). Transformants containing inserts 
(white colony) were identified via blue-white colony screening from agar plates coated 
with IPTG and 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal). Plasmids were 
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purified from single colonies and the desired inserts were subsequently subcloned into the 
pBluescript II vector using SacII and PstI restriction sites. Transformants containing inserts 
were identified via blue-white colony screening and the orientation of the inserts was 
determined through DNA sequencing (Genewiz). Based on the orientation of the DNA 
inserts, anti-sense and sense probes were synthesized using T3 and T7 RNA polymerases 
(Roche Life Science) with PstI or SacII linearized vector as template respectively. A 
Digoxigenin (DIG) label was incorporated in the probes through DIG labeled UTPs (DIG 
RNA labeling mix, Roche Life Science). All procedures involved use of RNAase free water 
(Sigma).  
All subsequent procedures including hydrolysis of RNA probes, testes preparation and in 
situ hybridization were performed as previously described.92,93 Imaging of the testes was 
performed using a Zeiss HXP120C Apotome microscope. 
4.2.3 Fertility testing  
     Newly eclosed single males of desired genotype were mated with two virgin yw females 
each in vials with standard yeast, molasses, cornmeal and agar medium. Mating was 
allowed for 7 days at 25 °C after which adults were removed and vials were evaluated for 
fertility and fecundity (number of progeny produced by each male). The progeny emerging 
from each vial were quantified from day 10 to day 18. If any of the adults died during the 
mating period, the vial was excluded from analysis.  
4.2.4 Design of UAS-shmiRNA constructs for transgenic Drosophila  
     Guidance for generating transgenic RNAi Drosophila strains was provided by Dr. 
Shekerah Primus (Van Doren Lab, Dept. of Biology, JHU). The open reading frame of 
CG6279-RA was analyzed for potential siRNA sites (21nt) by using the DSIR program 
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(Design of Small Interfering RNA).94 Sequences targeting CG6279-RA, both CG6279-RA 
and CG6279-RB and 5’-untranslated region (UTR) of CG6279-RB were selected (Table 
4-1). Scanning for potential off-target sites was performed as previously described.95 
  
Table 4-1. Chosen siRNA sequences using DSIR 
Isoform Sequence (5’-3’) 
CG6279-RA specific  
Sense  GGAAGUGUGGAGAGAUAAUGA 
Antisense  AUUAUCUCUCCACACUUCCUU 
  
CG6279-RA and RB  
Sense  GCAUUACUACAACGAGAUAUC 
Antisense UAUCUCGUUGUAGUAAUGCCU 
  
CG6279-RB 5’ UTR  
Sense (R)a GCAGUUACAUCUUGAAGCACC 
Antisense (R)a UGCUUCAAGAUGUAACUGCUU 
 
Cloning of the DNA sequences into the Valium 20 vector for generating short hairpin micro 
RNA (shmiRNA) constructs followed a protocol provided by the Transgenic RNAi Project 
(TRiP).96 Incorporation of insert was confirmed by DNA sequencing (Genewiz.) Vectors 
with the desired inserts were purified by midi-prep (GeneJet plasmid midiprep kit, Thermo 
Scientific) and 40 µg of each vector (1µg/µl) was shipped to Bestgene Inc (Chino Hills, 
CA) for injection into embryos from strain attP40 containing an attP recombination site on 
the 2nd chromosome to generate UAS-shmiRNA-A, UAS-shmiRNA-AB and UAS- shmiRNA-
B strains. Vermillion+ screening of Drosophila transformants was provided by Bestgene 
Inc. Presence of the insert for shmiRNA within the genome was confirmed by PCR and 
agarose gel electrophoresis from single males using the forward primer 5’-
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ACCAGCAACCAAGTAAATCAAC-3’ and reverse primer 5’-TAATCGTGTGTGATG-
CCTACC-3’.  
4.2.5 Microscopic analysis of Drosophila testes 
Males were dissected to isolate intact testes using a dissection microscope. The testes were 
mounted on a microscopic slide using phosphate buffered saline. The morphology of the 
testes was examined via phase contrast microscopy using a Zeiss HXP120C Apotome 
microscope. At least 10 pairs of testes for each male genotype were evaluated by 
microscopy. 
 
4.3 Results  
4.3.1 In situ hybridization for detection of CG6279 transcription 
     In order to probe the region of the Drosophila testes that shows presence of CG6279 
mRNA, we designed anti-sense RNA probes. One of the probes specifically targeted the 
N-terminal domain of CG6279-RA and another targeted the deiodinase domain common 
to both CG6279-RA and CG6279-RB. The testes were analyzed for color development 
using an alkaline phosphatase (AP) conjugated antibody targeting the DIG labeled RNA 
probes and AP substrate 5-bromo-4-chloro-3-indolyl phosphate with nitro blue tetrazolium 
salt. A strong signal was observed in the region occupied by post meiotic germ cells mainly 
spermatocytes, spermatids and elongated spermatids but not closer to the tip where germ 
cells in early stages of spermatogenesis are housed (Fig. 4-4A and B) as indicated in the 
schematic representation depicted in Fig. 4-3.   
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Figure 4-4. In situ hybridization of Drosophila testes with DIG labeled RNA probes. Anti-
sense probes targeting CG6279-RA only (A) and both CG6279-RA and RB (B) show 
intense staining in the region of the testes housing post meiotic germ cells. Region of testes 
normally occupied by early germ cells undergoing mitotic division is indicated by (*).97,98 
Corresponding sense RNA probes (C and D) were used as controls. Scale bars represent 
50 µm. 
 
The region of testes that are stained and their intensity of staining is similar for the antisense 
RNA probe targeting CG6279-RA only as well as the probe targeting both isoforms 
(CG6279-RA and CG6279-RB). Sense RNA probes (controls) did not show any staining 
pattern (Fig. 4-4 C and D). 
4.3.2 Fertility and testes phenotype of UAS-RNAi strains from VDRC 
     UAS-RNAi strains from VDRC targeting CG6279 transcripts were initially tested in 





and c587-GAL4 driving expression in somatic cells. UAS-105378 RNAi targets CG6279-
RA while UAS-37267 RNAi targets both CG6279-RA and CG6279-RB (Appendix Fig. 
C1). Males of the genotype eya-GAL4/UAS-105378 RNAi displayed 50% sterility (7 of 14 
eya-GAL4/UAS-105378 RNAi males tested were sterile while all control males were fertile) 
and a 92% decrease in fecundity (average number of progeny per eya-GAL4/UAS-105378 
RNAi male was 11 compared to 141 per control male). Other GAL4-UAS-RNAi systems 
did not show significant difference compared to controls (Fig. 4-5).   
     Males of the genotype eya-GAL4/UAS105378 RNAi were dissected and their testes were 
analyzed by phase-contrast microscopy. A phenotype was observed showing aggregation 
of cells during the late stages of spermatogenesis (Fig. 4-6A) with very few or no motile 
sperm. In contrast, the control (UAS-105378 RNAi/+) showed normal morphology (Fig. 4-






Figure 4-5. Fertility of male Drosophila expressing UAS-105378 RNAi (A) and UAS-
37267 RNAi (B) driven by GAL4 under control of the indicated promoter. N represents the 
number of individual males tested. Error bars represents standard deviation from average 
number of progeny produced. Control males are of genotype +/UAS-RNAi. 
     
     
Figure 4-6. Phase contrast microscopy images of Drosophila testes. (A) Testis from eya-
GAL4/UAS-105378 RNAi males. Late stage cell aggregation phenotype is indicated with 
(*). (B) Control from +/UAS-105378 RNAi male. Males were maintained at 25 °C for 3 to 
4 days after eclosion prior to dissection. Scale bar represents 100 µM. 
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4.3.3 Design of UAS-shmiRNA transgenic Drosophila strains and evaluation of testes 
phenotype 
     The transgenic Drosophila strains from VDRC generate long dsRNA from inverted 
repeat inserts (300-500 bp) under control of a UAS promoter. The dsRNA is further 
processed by dicer to generate siRNAs.99 In order to selectively target the CG6279-RB 
encoding only the deiodinase domain of CG6279, we designed a short hairpin micro-RNA 
targeting the 5’UTR of CG6279-RB (UAS-shmiRNA-B) which is not common to CG6279-
RA. We also designed UAS-shmiRNA-A and UAS-shmiRNA-AB that target the isoform A 
transcript and the common region of both transcripts respectively (Appendix Fig. C2) to 
further verify observations with the VDRC strains.  
     We evaluated eya-GAL4/UAS-shmiRNA males for a testes specific phenotype. All eya-
GAL4/UAS-shmiRNA strains were maintained at 29 °C as opposed to 25 °C to maximize 
GAL4 activity. A late stage cell aggregation phenotype with few or no motile sperm was 
observed with all 3 UAS-shmiRNAs (Fig. 4-7A to C). This phenotype was similar to 
previously observed phenotype in tested of eya-GAL4/UAS105378 RNAi males. However 
eya-GAL4/+ control males not encoding UAS-RNAi also showed a similar late stage 
phenotype (Fig. 4-7D). Additional germ cell specific (nos-GAL4), somatic cell specific (tj-
GAL4) and general GAL4 (ubi-GAL4) drivers failed to produce any testes phenotype in 
combination with UAS-RNAi at 29 °C. 
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Figure 4-7. Phase contrast microscopy images of Drosophila testes from eya-GAL4/UAS-
shmiRNA-A (A), eya-GAL4/UAS-shmiRNA-B (B), eya-GAL4/UAS-shmiRNA-AB (C) and 
eya-GAL4/+ control males (D). Late stage cell aggregation phenotype is indicated with (*). 
Males were maintained at 29 °C for 3-4 days prior to dissection. Scale bar represents 100 
µM. 
 
4.4 Discussion  
     High expression of CG6279 in the testes of Drosophila males reported previously 
published studies87, 88 was confirmed through in situ hybridization experiments using anti-
sense RNA probes targeting the CG6279 mRNA. The staining pattern revealed high 
expression of the dehalogenase gene in late stages of spermatogenesis including regions 
housing elongated spermatids. RNA probe targeting CG6279-RA that also includes a large 
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N-terminal domain and the RNA probe targeting the deiodinase domain of both CG6279-
RA and CG6279-RB show similar staining patterns and signal intensity.  
     High expression of the dehalogenase gene in the testes is suggestive of an important 
function in spermatogenesis. We initially investigated the effect of suppressing the 
CG6279 transcript in cell-type specific (germ cell and somatic cell) experiments on male 
fertility with RNAi transgenic Drosophila from VDRC targeting CG6279. Males  
expressing RNAi targeting CG6279-RA using a somatic cell specific promoter ‘eya’ 
displayed over 10-fold lower fecundity (50% of males tested were sterile) compared to 
controls lacking the eya-GAL4  driver. Germ cell specific RNAi expression did not affect 
fertility or fecundity. This indicated that the dehalogenase gene could have a role in somatic 
cyst cells. Microscopic evaluation of the testes from eya-GAL4/UAS-105378 RNAi males 
showed a late stage cell aggregation phenotype. This phenotype was observed in the region 
of the testes just following the region in which CG6279 is transcribed in high levels (Figs. 
4-4 and 4-6).          
     Previous studies have indicated more efficient gene silencing by shmiRNA compared 
to siRNA derived from long dsRNA.100 In addition, RNAi through expression of long 
dsRNAs has been shown to result in off-target gene silencing.95 Therefore to confirm our 
preliminary observations and target each transcript isoform selectively, additional 
transgenic Drosophila strains encoding shmiRNA targeting CG6279 transcripts were 
generated. UAS-shmiRNA-A, UAS-shmiRNA-B and UAS-shmiRNA-AB expression driven 
by eya-Gal4 produced the same male testes phenotype as previously observed with UAS-
105378 RNAi expression driven by eya-GAL4. However, eya-GAL4/+ control males that 
do not encode any RNAi showed the same phenotype suggesting that the original 
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phenotype observed was likely a false positive and did not result from CG6279 gene 
silencing but was related to the eya-GAL4 transgene itself. 
     We were unable to reproduce the phenotype observed for eya-GAL4 driven RNAi 
expression using any other germ cell or somatic cell specific GAL4 driver and UAS-RNAi 
combination including a general strong driver like ubi-GAL4. 
     In conclusion, we were unable to determine the effect of CG6279 gene silencing on 
Drosophila spermatogenesis using RNA interference. It is possible that gene silencing was 
not efficient for CG6279 using the GAL4–UAS-RNAi system and the observed phenotype 
was an artifact of the eya-GAL4 transgene. Editing of CG6279 at the genomic level to 
generate CG6279 loss of function Drosophila strains would enable investigation of the 
biological role of G6279 most definitively. 
 
4.5 Summary 
     The expression of the CG6279 gene encoding Drosophila halotyrosine dehalogenase in 
the testes was confirmed by in situ hybridization using antisense RNA probes. Gene 
silencing via RNA interference targeting CG6279-RA driven by somatic cell specific eya-
GAL4 resulted in lower fertility and fecundity of males due a late stage cell aggregation 
testes phenotype with few or no motile sperm. However this phenotype was also observed 
in control male testes devoid of UAS-RNAi but encoding the eya-GAL4 driver system. The 
phenotype was not reproduced using any other GAL4 driver. Therefore the effect of 
CG6279 gene silencing using RNA interference on Drosophila testes was inconclusive and 




Chapter 5: CRISPR/Cas9-based editing of a Drosophila dehalogenase gene 
5.1 Introduction 
     The gene encoding the dehalogenase enzyme (CG6279) is highly expressed in 
Drosophila testes in the late stages of spermatogenesis. RNAi experiments aimed at 
CG6279 silencing in the testes were inconclusive. An alternative approach to affect 
dehalogenase expression would eliminate the need for targeting the mRNA through RNAi. 
In the past few years, a RNA guided (CRISPR) DNA nuclease (Cas9) system has been 
widely adopted for genome editing due to its simplicity of design.101 
     Clustered regularly interspaced short palindromic repeats or CRISPR are DNA repeats 
separated by spacer sequences found in prokaryotic genomes and are a component of 
prokaryotic defense mechanisms against invading phages and viruses.102 CRISPR RNA 
delivers an associated endonuclease to complementary DNA through base pairing. The 
DNA target is then cleaved by the endonuclease resulting in double stranded breaks 
(DSB).103 The CRISPR-associated endonuclease (Cas9) from S. pyrogenes has been shown 
to require a single guide RNA (gRNA) recognizing a 20 nucleotide DNA sequence with 
an NGG sequence (protospacer adjacent motif or PAM) immediately adjacent to it. Cas9 
cleaves the target DNA three nucleotides upstream of PAM (Fig. 5-1).104 Earlier techniques 
for genome editing involved programmable nucleases such as zinc finger nucleases 
(ZFNs)105 and transcription activator-like effector nucleases (TALENS)106 but these 
required protein engineering for each target sequence recognition. Engineering these 
nucleases in the genomic context for multiple targets is challenging, laborious and requires 
extensive validation for each individual target sequence.103,107 CRISPR/Cas9 allows 
precise targeting of any 20 nt DNA sequence adjacent to a PAM through routine 
63 
 
replacement of gRNA. This ease of design has led to the rapid replacement of older genome 
editing technologies with CRISPR/Cas9.  
 
 












Figure 5-1. DNA recognition by CRISPR/Cas9. Cas9 (blue) is guided by a single chimera 
between the RNA component targeting the DNA sequence of interest (crRNA, red) and the 
RNA associating with Cas9 (tracrRNA, yellow) to form the guide RNA (gRNA). PAM is 
indicated in green. Cleavage sites are indicated by wedges. Figure adapted from Jinek et 
al.104  
 
     CRISPR/Cas9 has been effectively used in Drosophila to disrupt gene function by 
inducing double stranded breaks at targeted genes that are subsequently repaired by non-
homologous end joining to produce small insertions and deletions at target sites causing 
frame-shift, missense or nonsense mutations.108-111 Using 2 gRNAs targeting the 5’end and 
3’end of a fruitfly gene locus, defined deletions have been introduced to generate null 
mutants.108,110 Homology directed repair (HDR) has been employed for precise gene 
editing through CRISPR/Cas9 in Drosophila.110,112 For HDR, a DNA repair template with 
flanking homology arms upstream and downstream of the DSB and the desired insert or 







5-2). Both single strand oligodeoxynucleotide (ssODN) repair templates (less than 200 bp) 
as well as long double stranded DNA for incorporation of large exogenous sequences 
including screenable markers have been successfully employed in Drosophila. Transgenic 
fly strains constitutively expressing the Cas9 enzyme in the germline (nos-Cas9 and vasa-
Cas9) are available for engineering inheritable mutations through germline 
engineering.108,112   
 
      




    




Figure 5-2. Homology directed repair (HDR) following double stranded break (DSB) by 
Cas9. Figure is adapted from Sander and Joung.103   
 
       In this chapter we describe editing the CG6279 gene encoding the dehalogenase 
enzyme to generate loss of function mutant fruitfly strains followed by testing males 
carrying these mutations for fertility to assess whether the halotyrosine dehalogenase is 
essential for spermatogenesis.  
 
Cas9 induced DSB 
Donor template 
HDR 
Precise editing   
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5.2 Experimental Procedures 
5.2.1 Design of gRNAs for CG6279 editing   
      Initial guidance for CRISPR editing in Drosophila was provided by Caitlin Anderson 
and Dr Robert Johnston (Dept. of Biology, JHU). The CG6279 gene (chromosome 3L, 
bases 11093371 to 11096245)65 was analyzed for potential CRISPR sites using the 
‘CRISPR Optimal Target Finder’ algorithm.112 A pair of CRISPR target sites was selected 
for gene deletion (Appendix Fig. D1). A CRISPR target site closest to codon GAG 
encoding active site Glu-154 (Appendix Fig. D1) was selected for introduction of a single 
nucleotide mutation resulting in codon change to CAG and an amino acid substitution to 
Gln via HDR. The target nucleotide G (Appendix Fig. D1) was 18 bp upstream of the Cas9 
cut site. CRISPR sites were chosen based on the low number of potential off-target sites 
(no more than 6) and at least 3 mismatches between the selected gRNAs and off-target sites 
(one of which is 12 or fewer bp upstream of the PAM) (Appendix Fig. D2). Sense and 
antisense oligonucleotides encoding the gRNAs were purchased from IDT and cloned into 
the pCFD3-U6:3-gRNA vector using published protocols.113,114 
     A ssODN repair template with 60-70 bp homology arms flanking the Cas9 cut sites was 
designed for HDR following gene deletion (Appendix Fig. D3, ssODN-1). An EcoRI 
restriction site was included between the flanking regions of the repair template for 
potential screening of mutants. The ssODN repair template for introducing the E154Q 
mutation included the targeted mutation as well as another silent mutation destroying the 
PAM site to prevent repeated Cas9 cleavage after HDR has occurred (Appendix Fig. D3, 
ssODN-2). The ssODN templates for HDR were purchased from IDT.      
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     The pair of gRNA encoding vectors (250 ng/µl each) for targeted gene deletion and the 
ssODN template (100 ng/µl) were co-injected in Drosophila embryos expressing Cas9 in 
the germline (BDSC # 51323) by Bestgene Inc (Chino Hills, CA). The single gRNA 
encoding vector (500 ng/µl) and the ssODN repair template (100 ng/µl) for introducing the 
E154Q mutation were similarly co-injected in Drosophila embryos by Bestgene Inc. 
5.2.2 Genetic experiments 
     All flies were raised on standard yeast, molasses, cornmeal and agar medium at 25°C. 
Larvae from surviving injected embryos were obtained from Bestgene Inc. Each injected 
embryo that developed into an adult was mated to MKRS/TM6B (balancers for 3rd 
chromosome81) Drosophila provided by the Xin Lab (JHU, Biology Dept.). 5 to 10 1st filial 
generation (F1) male progeny with the humeral phenotype (from the TM6B balancer) from 
each fertile cross were individually mated again with MKRS/TM6B balancer females. Male 
and female progeny from the 2nd filial generation (F2) with the humeral phenotype were 
mated to each other to establish individual Drosophila stocks. The 3rd chromosome (non-
balancer) in a particular stock has been inherited from the same F1 parent. Single 
homozygous (non-TM6B) 3rd filial generation (F3) males were screened by PCR for 
targeted mutations.   
5.2.3 Screening for mutations induced by CRISPR  
     A single male from each stock was evaluated for desired the mutation by PCR. The 
male was homogenized in 50 µl of buffer A (25 mM NaCl, 1mM EDTA, 10 mM TRIS pH 
8.2). Proteinase K (1 µl of 20 mg/ml stock, Thermo Scientific) was added to the 
homogenate and incubated for 1 hr at 37 °C after which homogenate was incubated at 98-
100 °C for 1 to 2 mins. An aliquot of homogenate (4 µl) was used as a template for a PCR 
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reaction using Taq DNA polymerase (Thermo Scientific) wherein forward primer 5’–
ACACTTTGCCGATCTTGGCG-3’ and reverse primer 5’-CAGTTCAAAGGAGTG-
GTGACC-3’ were used to amplify a 561 bp region spanning the dehalogenase domain of 
CG6279. Potential gene deletion mutants (CG6279Del) were further analyzed by flanking 
PCR with forward primer 5’–TCTCGCTCGCTCTTTTACTGCA-3’ and reverse primer 
5’-CTTACCGTAGCTATCGTTATCGA-3’ followed by sequencing of the PCR product 
(Genewiz).  
     For the E154Q mutant (CG6279E154Q), successful mutation of the codon from GAG to 
CAG introduces a PvuII restriction site (CAG^CTG). The 561 bp PCR product described 
above yields smaller fragments (301 bp and 260 bp) upon restriction digestion with PvuII 
upon if the codon is mutated. Identification of the CG6279E154Q mutant was subsequently 
performed by restriction digestion of the 561 bp PCR fragment described above with PvuII 
(NEB) prior to agarose gel electrophoresis. Appearance of fragments smaller than 561 bp 
(301 bp and 260 bp) indicated target mutation. Target mutation were confirmed by 
sequencing the undigested PCR products from potential mutants (Genewiz). 
5.2.4 Male fertility testing  
     The balanced deficiency (Df) fly stock for CG6279 carrying a deletion on chromosome 
3L (11070526 to 11247145) was obtained from the Bloomington Drosophila stock center 
(BDSC # 27578).115 Homozygous virgin females of genotype CG6279Del, CG6279E154Q 
and CG6279+ (yw flies) were mated with Df/TM6 males. Progeny males of genotype 
CG6279Del/Df, CG6279E154Q/Df and CG6279+/Df  (control) were tested for fertility and 




5.3 Results  
5.3.1 Deletion of CG6279 by CRISPR/Cas9 
     Two distinct CRISPR genome editing strategies were adopted to generate the desired 
dehalogenase null mutant Drosophila. The first approach involved deletion of CG6279 
from its genomic locus by employing 2 gRNAs, one targeting the 5’end and another 
targeting the 3’ end of the gene (Appendix Fig D1). Targeted deletion of CG6279 was 
designed to eliminate most of its open reading frame including start codon. Individual 
fruitfly stocks were produced such that flies in each stock inherited the 3rd chromosome 
from a single F1 progeny of a founder (individual fertile adult arising from each injected 
embryo). Single homozygous flies from each of the 35 individual stocks (representing 14 
founders) were screened by PCR. The absence of a 561 bp DNA fragment covering the 
dehalogenase domain of CG6279 indicated a potential gene deletion mutant. Three 
potential mutants were identified amongst the 35 stocks that were screened (Fig. 5-3A).  
 
                   
Figure 5-3. Agarose gel electrophoresis images for PCR products from screening for 
CG6279Del mutants. (A) Screening of stocks for CG6279Del mutants. Lanes 2, 3 and 4 are 
potential mutants (B) PCR products from potential mutants with primers flanking the 
CG6279 gene 467 bp upstream of start and 263 bp downstream of stop codon. M represents 
marker and C represents control (Vasa-Cas9 strain).   
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Additional flanking PCR was performed for the potential mutants from the initial screen 
and the expected PCR product (777 bp) was observed (Fig. 5-3B). Gene deletion was 
verified by sequencing the flanking PCR product from mutant stock represented in lane 1 
and this fly stock was used for further studies. 
5.3.2 Mutation of active site Glu codon by CRISPR/Cas9 
     The second strategy involved introducing an amino acid substitution (E154Q) in the 
active site of the dehalogenase domain of CG6279 through a single mucleotide mutation 
at the Glu-154 codon (GAG to CAG, see in vitro characterization in chapter 3) that would 
greatly reduce the enzyme’s catalytic efficiency. For screening, the same 561 bp PCR 
fragment described above was amplified as it covers the targeted codon. PCR products 
were digested with PvuII restriction endonuclease prior to agarose gel electrophoresis to 
identify mutants.  
     Screening of just 7 stocks derived from F1 progeny of distinct founders resulted in the 
identification of 3 potential mutants (Fig 5-4). PCR products from these potential mutants 
were sequenced to confirm the G to C mutation. Two of three mutants (lanes 4 and 5) 
showed an additional single nucleotide deletion 11 and 23 bases upstream of the targeted 
mutation respectively.  These deletions were likely due to imprecise HDR and resulted in 
a codon reading frame shift at the point of deletion. The mutant indicated in lane 6 did not 
show any additional nucleotide insertions or deletions up to 278 bases upstream and 241 
bases downstream of the targeted mutation. The fly stock represented by lane 6 was used 




                    
Figure 5-4. Agarose gel electrophoresis image for PCR products from screening for 
CG6279E154Q mutants. Lanes 4, 5 and 6 are potential hits. M represents marker and C 
represents control (Vas-Cas9 strain).   
 
5.3.3 Fertility of CG6279 null mutant males 
     CG6279 null mutant males over a deficiency (Df) background were tested for fertility. 
Df strains contain defined deletions across a few or several genes on a particular 
chromosome.117 Drosophila stocks containing these deletions are maintained as 
heterozygous and balanced stocks. Df strain 27578 from BDSC contains a deletion 
encompassing the CG6279 locus. A Df background facilitates assessment of individual 
alleles of a gene for phenotypic manifestations. It also enables the exclusion of any off-
target chromosomal aberrations introduced through CRISPR/Cas9. Drosophila males of 
genotype CG6279Del/Df, CG6279E154Q/Df and CG6279+/Df contain a single copy of either 
the targeted CG6279 deletion, the E154Q mutation at CG6279 or the wild-type CG6279 
respectively. These males were individually mated to 3 yw females for a period of 5 days.  
The parent flies were then removed from the vials and the number of adult progeny 
produced (fecundity) was evaluated for each male fly. Of the 22 CG6279Del/Df males 
tested, 20 were fertile while 20 of 21 CG6279E154Q/Df males were fertile. All 16 
CG6279+/Df control males were fertile. The average number of progeny produced by 
CG6279Del/Df males (102) and CG6279E154Q/Df males (105) were similar to CG6279WT/Df 
control males (100) (Fig. 5-5).  
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Figure 5-5. Average number of progeny produced by CG6279Del/Df, CG6279E154Q/Df and 
CG6279+/Df  (positive control) males when mated to 3 yw females over 5 days. N indicates 




     CRISPR/Cas9 editing of the dehalogenase gene was efficient and the mutant strains 
were obtained through relatively few rounds of screening. All 3 Drosophila lines showing 
deletion of CG6279 derived from the same founder. This indicates that the CRISPR/Cas9 
induced modification was successfully transmitted though the germline and stably 
inherited by the progeny. One of the 14 founders screened (7%) produced progeny with 
the targeted CG6279 gene deletion while one of 7 founders (14%) screened produced 
progeny with the targeted GAG to CAG point mutation within CG6279 without any 
additional aberrations. The aforementioned numbers do not reflect the actual efficiencies 
of CRISPR editing since screening of fly strains derived from additional founders was 
discontinued when the desired mutants were identified.  
72 
 
     The dehalogenase gene CG6279 from Drosophila melanogaster encodes an additional 
N-terminal domain of unknown function in addition to the dehalogenase domain and splice 
variants of the gene transcript are predicted to result in 2 protein isoforms (isoform A and 
isoform B) with and without the N-terminal domain (Appendix Fig. B1).  This additional 
N-terminal domain could have a function distinct from that of the dehalogenase domain. 
The CG6729Del mutant strain lacks both domains whereas the CG6279E154Q mutant strain 
encodes a catalytically deficient dehalogenase domain. Comparison of the fertility of males 
of each of these genotypes should enable identification of the relative importance of each 
individual domain towards spermatogenesis in Drosophila.  
     Deletion of CG6279 from the Drosophila genome did not significantly alter the fertility 
of males. This was surprising since in situ hybridization of Drosophila male testes (Chapter 
4) clearly indicated high levels of the CG6279 transcript with peak expression in the post-
meiotic stages. Consistent with the CG6279 gene deletion, the E154Q mutation in the 
active site of the dehalogenase domain also did not significantly affect the fertility of males. 
This indicates that the dehalogenase enzyme is not essential for fertility of male Drosophila 
and by extension not critical for spermatogenesis. It is possible that an alternate pathway 
compensates for the loss of the dehalogenase function in spermatogenesis. Further 
investigation would be required to identify possible rescue pathways for loss of 
dehalogenase activity. 
5.5 Summary 
        The CG6279 gene encoding the dehalogenase enzyme in Drosophila was successfully 
edited using CRISPR/Cas9 technology.  A mutant Drosophila strain was generated with a 
deletion at the CG6279 locus spanning almost the entire open reading frame (2211 bp of 
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2274 bp) including the start codon (CG6279Del). A second mutant strain was also generated 
with the active site Glu-154 codon (GAG) changed to a Gln codon (CAG) via homology 
directed repair rendering the dehalogenase catalytically deficient without affecting the 
additional N-terminal domain as seen in isoform A of the gene transcript (CG6279E154Q). 
Drosophila males of genotype CG6279Del/Df, CG6279E154Q/Df and CG6279+/Df (control) 
were tested for fertility by mating to wild-type (yw) females. Despite the high expression 
of CG6279 in Drosophila testes during the post-meiosis stages of spermatogenesis as 
demonstrated in Chapter 4, both CG6279Del/Df and CG6279E154Q/Df males displayed 
fertility similar to CG6279+/Df males (control). This indicated that deletion of CG6279 
(including the additional N-terminal domain and dehalogenase domain) as well as 
selectively rendering the dehalogenase domain of CG6279 catalytically deficient  does not 
significantly impact fertility of males. The dehalogenase encoding gene is likely not critical 










Chapter 6: Probing the metabolic activity of the Drosophila halotyrosine 
dehalogenase 
6.1 Introduction 
     Little is known about halotyrosine function in arthropods. Halotyrosines are 
incorporated into scleroproteins63,118 and may be produced as a result of peroxidase activity 
during insect cuticle sclerotization.64 These halotyrosines could exert toxicity through 
disruption of cellular pathways. I-Tyr competes with the natural substrate Tyr and inhibits 
tyrosine hydroxylase with inhibition constants (Ki) in the sub-micromolar range.119,120 
Tyrosine hydroxylase catalyzes the conversion of Tyr to 3,4-dihydroxyphenylalanine 
(DOPA), a precursor to catecholamine neurotransmitters (Fig. 6-1).121 
                   
Figure 6-1. Reaction catalyzed by tyrosine hydroxylase. 
      
 
Synthesis of the catecholamine neurotransmitter dopamine is well conserved between 
vertebrates and Drosophila and involves decarboxylation of DOPA by dopa decarboxylase 
to produce dopamine.122 Dopamine has been demonstrated to modulate a number of 
behaviors in Drosophila including locomotion,123 sleep and arousal,124 memory and 
olfaction125 and mating behavior.126 Previously, I-Tyr has been used as an inhibitor to 
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deplete dopamine in neurological experiments involving Drosophila larvae.127 Feeding of 
I-Tyr to Drosophila larvae at high concentrations (10 to 15 mg/ml of yeast paste media) 
was demonstrated to increase mortality, likely through inhibition of tyrosine hydroxylase 
since this effect could be rescued through co-feeding of L-DOPA.128  
         The Drosophila life cycle consists of four distinct stages.129 The 1st stage is the egg 
or the embryonic stage. Within the fertilized egg, the embryo develops into the larva (2nd 
stage) and emerges from the egg in about 24 hrs post fertilization. Within the larval stage, 
there are 3 sub-stages or instars. The 1st instar (L1) larva hatches from the egg and this 
stage lasts for about 24 hrs.130 The L1 larva then undergoes molting into the 2nd instar larva. 
The 2nd instar larva molts again into the 3rd instar larva. The larvae feed aggressively and 
undergo rapid growth and size increase from the 1st to the 3rd instar. The 3rd instar larva 
develops into the pupa (3rd stage). Within the pupa, the larval tissues undergo extensive 
remodeling. The adult (4th stage) finally emerges from the pupa. 
     The gene CG6279 encoding the halotyrosine dehalogenase is also expressed during the 
Drosophila pre-adult stages in the fat body (Chapter 4, Fig. 4-2), an organ compared to 
vertebrate liver for serving as the insect’s metabolic center.131,132 The dehalogenase may 
function in larvae to protect the organism from halotyrosine toxicity. In this chapter, we 
probe whether the dehalogenase gene provides a metabolic advantage to Drosophila 
through feeding halotyrosines to dehalogenase mutant strains (CG6279Del and 
CG6279E154Q) and control strains (CG6279WT and yw) in the larval and adult stages of the 




6.2 Experimental Procedures 
6.2.1 Materials and Drosophila media preparation  
     Giant apple juice (frozen) was purchased from Giant grocery. Methyl 4-
hydroxybenzoate (methyl paraben or Tegosept) and erioglaucine disodium salt (FD&C 
blue 1) were purchased from Sigma Aldrich. Agar was purchased from Becton, Dickinson 
and Company. Stock solutions of 3-halotyrosines and Tyr were prepared in 0.1 N 
hydrochloric acid. Concentrations of 3-halotyrosine and Tyr stock solutions were 
determined based on extinction coefficients previously described.63 Stock solution of 
Tegosept was prepared in ethanol. Stock solutions of sodium iodide (NaI), sodium bromide 
(NaBr) and FD&C blue 1 dye were prepared in water. Standard yeast, molasses, cornmeal 
and agar feeding medium (Appendix Table E1) was obtained from the JHU Biology Dept.       
6.2.2 Drosophila strains 
     Homozygous dehalogenase mutant strains CG6279Del and CG6279E154Q generated 
through CRISPR editing as described in Chapter 5 were used in both larval and adult 
feeding studies. For generating the CG6279WT control strain, un-injected vasa-Cas9 (BDSC 
# 51323)133 flies were crossed with the MKRS/TM6B 3rd chromosome balancer strain 
similar to the procedure described in Chapter 5 (5.2.2). The Drosophila strain yw, 
commonly used as a reference strain in laboratory experiments134,135 was employed as a 
control in addition to the CG6279WT strain in all feeding experiments and was obtained 
from Dr Xin Chen (JHU, Biology Dept.).  
6.2.3 Drosophila larval halotyrosine feeding  
     For larval halotyrosine feeding experiments, mature egg laying adults of the desired 
genotype were transferred to vials containing apple juice agar medium (40% Giants apple 
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juice, 1.5% Agar and 0.05% Tegosept) and allowed to lay eggs. Adults were removed after 
24 hrs and L1 larvae were collected between 24 to 30 hours after egg laying. Standard 
feeding media (Appendix Table E1) was supplemented with halotyrosine or control 
compounds and FD&C blue 1 dye (0.007% w/v). An equivalent amount of sodium 
hydroxide solution (previously titrated with 0.1 N hydrochloric acid) was added to feeding 
medium to neutralize the acid contributed by the 3-halotyrosine and Tyr stock solutions. A 
total of 50 L1 larvae were transferred to each individual vial. Food consumption by the 
larvae was detected through ingestion of the dye (Appendix Fig. E1). Vials were 
maintained at 25 °C and the number of larvae surviving to adulthood were quantified.  
6.2.4 Drosophila adult halotyrosine feeding  
     One day old male and female adult flies (25 each) were transferred to a vial containing 
tissue (KimWipe, Kimberly Clark) soaked in 3 ml of apple juice-halotyrosine feeding 
mixture (75% v/v apple juice, 2 mM halotyrosine, 0.05% w/v methyl paraben and 0.05% 
w/v FD&C blue 1 dye and an equivalent amount of sodium hydroxide solution, previously 
titrated with 0.1 N hydrochloric acid, to neutralize the acid contributed by the 3-
halotyrosine stock solutions). Consumption of liquid feeding mixture by adult flies was 
confirmed through ingestion of dye (Appendix Fig. E2). The adult flies were maintained 
on apple juice-halotyrosine mixture for at 25 °C for 5 days and number of surviving adults 




6.3 Results  
6.3.1 Drosophila larval survival in halotyrosine containing feeding media  
     L1 larvae were raised on standard feeding medium supplemented with I-Tyr at 4 
different concentrations of 100, 150, 200 and 300 µM respectively. A concentration 
dependent increase in I-Tyr toxicity was observed for larvae from all strains tested (Fig. 6-
2). None of the larvae from the dehalogenase mutant strains (CG6279Del and CG6279E154Q) 
survived to adulthood when raised on medium containing 300 µM I-Tyr. CG6279WT control 
larvae had a negligible average survival rate of 2% while larvae from the yw strain 
displayed the highest average survival rate of 18% at 300 µM I-Tyr. In medium containing 
200 µM I-Tyr, CG6279E154Q larvae had a 0% survival rate which was significantly lower 
than average survival rates of both control strains, CG6279WT (28%, p-value <0.05 ) and 
yw (58%, p-value <0.01) (Fig. 6-2). However, CG6279Del larvae displayed a higher average 
survival rate (16%) than CG6279E154Q larvae at 200 µM I-Tyr. This was significantly lower 
than the average survival rate of yw larvae (p-value <0.01) but not significantly lower than 
CG6279WT larvae (p-value >0.05). At 150 µM I-Tyr, CG6279Del larvae displayed a high 
average survival rate (over 90%) that was very similar to the average survival rates of 
larvae from both the control strains. However, CG6279E154Q larvae displayed a 
significantly lower average survival rate (32%) compared to both CG6279WT and yw 
control larvae (p-value <0.01). Even at 100 µM I-Tyr, CG6279E154Q larvae displayed a 
lower average survival rate of 64% compared to larvae from the 3 other genotypes that 
showed average survival rates over 90%. Most of the larvae that progressed to pupation 
(≤95%) developed into adult flies indicating that increased mortality from I-Tyr toxicity 
was manifested prior to pupation. 
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     Drosophila larvae from each of the aforementioned strains were also raised on medium 
containing the products of the dehalogenation reaction (Tyr, bromide and iodide) as 
controls. Tyr concentration was similar to the highest halotyrosine concentration added 
(1500 µM) while NaI and NaBr concentrations were similar to highest I-Tyr and Br-Tyr 
concentrations (300 µM and 1500 µM) respectively. Chloride was excluded due to its 
ubiquity in biological systems. The survival rates for larvae from the dehalogenase mutant 
strains as well as control strains exceeded 85% on medium supplemented with these control 
compounds indicating that these were not toxic to the larvae at concentrations comparable 
to the halotyrosines (Appendix Fig E3).  
6.3.2 Drosophila adult survival in halotyrosine containing feeding media 
     One day old adult Drosophila (25 males and 25 females) were maintained for 5 days on 
apple juice containing halotyrosines at a high concentration (2 mM). A liquid feeding 
medium was used for the adults to facilitate higher intake through the proboscis compared 
to standard feeding media of soft solid consistency. CG6279Del and CG6279E154Q adult 
Drosophila exhibited high tolerance to all halotyrosines with over 80% average survival 
rates over 5 days. (Fig. 6-4). The survival of CG6279Del and CG6279E154Q mutant strains 
was comparable to both CG6279WT and yw control strains.  
      
     
 




      I-Tyr is the most lethal of the 3 halotyrosines when fed to Drosophila larvae while Cl-
Tyr is the least toxic. Higher toxicity of I-Tyr may be due to stronger inhibition of tyrosine 
hydroxylase by I-Tyr compared to Br-Tyr and Cl-Tyr. However, toxicity through other 
mechanisms cannot be ruled out. Introduction of an E154Q mutation that renders the 
dehalogenase catalytically deficient results in significantly increased susceptibility of the 
larvae to I-Tyr toxicity compared to larvae from control strains containing the wild-type 
gene. Surprisingly, larvae with a genomic deletion of the dehalogenase gene were only 
modestly more sensitive to I-Tyr compared to a wild-type control. Variability in I-Tyr 
toxicity was also evident between the two control strains. Differential toxicity of I-Tyr 
towards CG6279E154Q and CG6279Del mutant larvae was unexpected given that larvae from 
both strains lack the ability to efficiently metabolize I-Tyr. It is possible that a catalytically 
deficient dehalogenase increases the sensitivity to I-Tyr through an off pathway effect 
relative to complete absence of the enzyme.     
     Very high concentrations of Br-Tyr (5-fold higher than the highest I-Tyr concentration 
tested) were required to induce toxicity. The average survival rate of CG6279Del larvae in 
Br-Tyr supplemented media was higher than the survival rates of larvae from control 
strains suggesting Br-Tyr at this high concentration may exert toxicity faster than it can be 
metabolized. Cl-Tyr was generally well tolerated at concentrations equivalent to Br-Tyr by 
larvae from both mutant strains and the CG6279WT control strain precluding any 
comparative analysis. Only larvae from the yw control strain displayed sensitivity to Cl-
Tyr which is likely a peculiarity associated with that particular Drosophila strain.  
     Adult Drosophila from both mutant strains as well as the control strains did not display 
significant variation in survival rates (>80%) when maintained on apple juice containing 
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high concentrations each of halotyrosine for 5 days. This lack of toxicity is not so surprising 
for Br-Tyr and Cl-Tyr which were found to be significantly less toxic than I-Tyr in the 
larval stages. However, I-Tyr was also well tolerated by adult Drosophila at high 
concentration (2000 µM). It is possible that the adults are more resistant to I-Tyr toxicity 
than the larvae if dopamine signaling is more critical for survival of larvae. Alternatively, 
the physiological levels of I-Tyr upon feeding to adults may be lower compared to larvae 
feeding on I-Tyr containing media due to the minimal feeding by the adults relative to more 
aggressive feeding by the larvae prior to metamorphosis. 
      
6.5 Summary  
          I-Tyr had been previously shown to be toxic to Drosophila larvae though inhibition 
of dopamine biosynthesis.128 To probe whether the Drosophila halotyrosine dehalogenase 
is metabolically active in vivo, we performed feeding assays for dehalogenase null mutant 
Drosophila strains in the larval as well as the adult stage using media supplemented with 
halotyrosines. Drosophila strains encoding the wild-type dehalogenase gene were used as 
controls. Amongst the halotyrosines, I-Tyr was most toxic to Drosophila larvae in a dose 
dependent manner while Br-Tyr and Cl-Tyr were significantly less toxic. The CG6279E154Q 
mutant larvae encoding a catalytically deficient dehalogenase enzyme were most 
susceptible to I-Tyr toxicity. Survival rates for CG6279E154Q larvae were significantly 
lower than for larvae from both control strains. Surprisingly, CG6279Del larvae lacking the 
dehalogenase gene did not display significantly higher susceptibility to I-Tyr toxicity 
compared to larvae from the CG6279WT control strain. Drosophila adults from both 
CG6279 mutant as well as control strains were more tolerant of halotyrosines including I-
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Tyr at high concentrations compared to the larvae. Based on significantly different 
susceptibilities to halotyrosine toxicity demonstrated by larvae from both dehalogenase 


















Chapter 7: Conclusions 
     Structural similarities between IYD and bacterial nitro-reductases were intriguing since 
IYD is the only mammalian member of a primarily prokaryotic enzyme superfamily. In 
order to determine whether the occurrence of IYD correlated with the need for iodide 
salvage, we defined an amino acid signature for deiodinase activity based on the co-crystal  
structure of mammalian IYD with its substrate (mmIYD·I2-Tyr).28 Conservation of the 
substrate interacting active site residues Glu-153, Tyr-157 and Lys-178 and FMN 
interacting Thr-235 were deemed to be indicative of IYD activity. We identified this amino 
acid signature in homologous proteins from diverse organisms including non-chordate 
invertebrates and prokaryotes, none of which are associated with TH synthesis nor have a 
thyroid gland. The kinetic characterization of selected IYD homologs from organisms 
belonging to diverse phyla within the animal kingdom as well as prokaryotic 
representatives revealed that these enzymes acted as deiodinases. This confirmed that 
substrate interacting residues Glu, Lys and Tyr as well as FMN interacting Thr are robust 
indicators of deiodinase activity. Presence of deiodinases in non-chordate invertebrates and 
prokaryotes suggested that the origin of IYD pre-dates the evolution of TH signaling. 
    Non-chordate invertebrates do not require iodide recycling for TH synthesis and 
alternative halotyrosines could be their primary substrates. The soluble domain of the IYD 
homolog from the model organism Drosophila melanogaster (dmIYD) was characterized 
in vitro to probe the scope of its catalytic activity as a representative of non-chordate 
invertebrates. Through substrate affinity and steady state kinetics, we found that I-Tyr, Br-
Tyr and Cl-Tyr are all possible substrates for dmIYD in vitro and either one or all of these 
87 
 
may be physiologically relevant. Thus dmIYD may serve generally as a halotyrosine 
dehalogenase. 
     The amino acid indicators of IYD activity may be further refined through probing the 
relative contributions of the active site residues. Previous studies with mammalian IYD 
provided limited information regarding the relative importance of Glu-153, Tyr-157 and 
Lys-178 residues interacting with the substrate zwitterion.29 Using dmIYD and its active 
site mutants we showed that the active site Glu residue is most critical for catalytic activity 
followed by the Lys residue while the Tyr residue did not significantly impact catalytic 
activity. Given the conservation of these residues in IYDs from mammals to prokaryotes, 
these findings should be broadly applicable to IYD homologs and further facilitate the 
annotation of potential IYDs within the nitro-FMN reductase superfamily. For example, 
putative NADH oxidases from Hyperthermus butylicus and Staphylothermus marinus 
(Accession WP_011822328.1 and WP_011839241.1 respectively) are likely deiodinases 
based on the conservation of the crucial Glu and Lys residues while the most dispensable 
Tyr residue is not conserved.  
     The biological function of halotyrosine dehalogenase in non-chordate invertebrates is 
unknown. Drosophila provided a promising model for in vivo investigations into its 
biological function. A peculiar feature of the dehalogenase gene from Drosophila, 
annotated as CG6279, was the presence of a large N-terminal domain of unknown function 
in addition to the dehalogenase domain. Splice variants of this gene with and without this 
N-terminal domain were also predicted. Previous genome-wide mRNA profiling studies in 
Drosophila indicated the highest expression of dehalogenase gene  in the testes.87,88 
Through in situ hybridization experiments using Drosophila testes, we confirmed high 
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expression of CG6279. Peak expression appears in the post-meiotic stages of 
spermatogenesis. We attempted CG6279 gene silencing using RNAi in the testes to probe 
the effects of gene suppression on male fertility but these experiments were inconclusive 
since only one transgene (eya-Gal4) used to drive RNAi expression (UAS-RNAi) resulted 
in an abnormal testes phenotype and a similar testes phenotype was observed control males 
encoding eya-Gal4 but not encoding UAS-RNAi. This phenotype was not reproduced by 
any other driver of RNAi expression further suggesting that the observed phenotype was 
likely due to the eya-Gal4 transgene rather than CG6279 gene silencing.  
     Using CRISPR/Cas9 gene editing technology as an alternative approach, we 
successfully generated two CG6279 null mutant Drosophila strains. The CG6279Del strain 
had a deletion in the genome spanning the CG6279 gene including the N-terminal and the 
dehalogenase domains. The CG6279E154Q strain incorporated a point mutation resulting in 
an amino acid substitution in the active (E154Q) of the dehalogenase domain that greatly 
diminished the catalytic efficiency of the enzyme in vitro. Despite the high expression of 
the CG6279 gene during spermatogenesis, we found that both loss of function mutations 
did not significantly affect the fertility of the Drosophila males indicating that CG6279 is 
not critical for spermatogenesis. Alternatively, a rescue mechanism might be triggered in 
the testes that compensates for loss of dehalogenase function but further experimentation 
would be required to investigate this possibility. 
     CG6279 gene expression was also reported in the fat body during larval and pupal stages 
of the Drosophila life-cycle.87,88 The insect fat body is homologous to the vertebrate liver 
serving as a center for carbohydrate, lipid and amino acid metabolism.131,132 Expression of 
the dehalogenase in the fat body suggested a metabolic role. Previous studies had indicated 
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that ingestion of I-Tyr was toxic to Drosophila larvae due to inhibition of tyrosine 
hydroxylase, a critical enzyme in dopamine biosynthesis.128 We reasoned that larvae from 
the CG6279Del and CG6279E154Q mutant strains would be more susceptible to halotyrosine 
toxicity compared to strains encoding the wild-type gene. I-Tyr was found to be more toxic 
to Drosophila larvae resulting in increased mortality at significantly lower concentrations 
compared to Br-Tyr and Cl-Tyr. Indeed, CG6279E154Q larvae were more susceptible to I-
Tyr toxicity and displayed significantly lower survival rates relative to control strains. 
Surprisingly, these results were not mimicked by the CG6279Del strain which did not 
display significantly lower survival rates relative to the CG6279WT control strain. Based on 
these results it is unclear whether the dehalogenase gene functions in a metabolic capacity 
and needs to be further investigated. This difference between the CG6279Del strain and 
CG6279E154Q strain may be related to the function of the additional N-terminal domain and 
requires further investigation. Additionally, the halotyrosines may exert other 
physiological effects that do not result in increased mortality of organism. Further 
experiments to measure the impact of halotyrosine consumption on Drosophila fertility, 
locomotion and lifespan may reveal additional effects of these compounds.  
     The physiological function of the halotyrosine dehalogenase in Drosophila remains 
enigmatic. Our in vivo investigations of dehalogenase gene function were guided by 
mRNA expression profiles and previous studies investigating the effects of halotyrosines 
on Drosophila. The mRNA expression may not correlate with protein expression for the 
dehalogenase due to post transcriptional regulation. Experiments involving detection of the 
dehalogenase in Drosophila tissues using specific antibodies or proteomic analysis by mass 
spectrometry could provide evidence of protein expression. It is also possible that loss of 
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function mutations of CG6279 result in more subtle phenotypes that may have escaped 























Appendix A: Supporting information for Chapter 2 
 
Table A1. Extinction coefficients for IYD homologs. 
IYD homolog ε280 (M-1 cm-1)  







                             aDetermined for truncated dpIYD (-55 amino acids, N-terminus) 
 
 
                     
 
 Figure A1. FMN depletion by BluB for detecting native activity was performed as 
previously described47 at room temperature. (A) Represents reaction containing 50 µM 
FMN, 50 µM BluB, 300 µM NADPH 180 nM SSuE in 20 mM TRIS at pH 7.9. Depletion 









                                  
 
Figure A2. Coomassie stained polyvinylidene difluoride (PVDF) blot for purified dpIYD 











Figure A3. Identification of N-terminus of dpIYD. Sequencing results from JHMI 
indicated the N-terminus as MXXESAIEQINE. The first amino acid was reported as a 
methionine (M). The following 2 amino acids could not be determined but the next 9 amino 
acids matched the dpIYD sequence indicating the N-terminus likely begins at Valine 56 







                                  
Figure A4. Identification of IYD from hydra (hmIYD). (A) Western blot of catalytically 
active protein fraction from hmIYD purification using His-tag mouse monoclonal antibody 
and goat anti-mouse antibody performed as per manufacturer procedures (Novagen). (B) 





Figure A5. Steady-state analysis of 125I-(I2-Tyr) turnover by IYD homologs. Initial rates 
of deiodination were determined by quantifying 125I- released by enzyme. Each data point 
represents an average of 3 independent observations and the error bars represent the 
standard deviation from that average. Kinetic constants are derived from the best fit of the 
data (solid lines) to the Michealis-Menten equation. All experiments conducted at 25 °C 
unless mentioned otherwise. All nonlinear curve fitting was performed using Origin 6.0 or 
7.0. Enzyme concentration represents the total protein concentration since addition of 













Appendix B: Supporting information for Chapter 3 















Figure B1. Proteins resulting from IYD encoding gene CG6279. Isoform A (accession 
NP_648433.1) includes the N-terminal domain in red and the deiodinase domain in black. 
Isoform B (accession NP_001163414.1) resulting from alternative splicing of CG6279 
















Figure B2. E. coli expression optimized gene sequence for dmIYD synthesized by Blue 























               
 
Figure B3. Standard curve for determination of Tyr produced by enzymatic turnover. 
Known concentrations of Tyr were spiked into enzymatic reaction mixtures lacking 
halotyrosine substrates and analyzed by HPLC. Ratio of area under curve (AUC) for m-
cresol (IS) to AUC for Tyr was plotted against concentration of spiked Tyr. Each point 
represents the average of 2 individual measurements. Equation obtained from linear 





               
 
Figure B4. Standard curve for determination of Tyr impurity (not enzymatically generated) 
in bromotyrosine. Known concentrations of Br-Tyr were added to reaction mixtures 
lacking enzyme and analyzed by HPLC. Ratio of area under curve (AUC) for m-cresol (IS) 
to AUC for Tyr was plotted against concentration of Br-Tyr. Each point represents the 
average of 2 individual measurements. Equation obtained from linear regression (indicated 
above) was used to calculate Tyr impurity contribution to total Tyr produced.  
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Figure B5. Standards for detection of Tyr after dmIYD turnover of the halotyrosines using 
reverse phase HPLC. All standards were incubated for 40 mins under conditions equivalent 
to the enzyme reactions i.e. 30 µM m-cresol, 200 mM KCl and 100 mM potassium 
phosphate pH 7.4 with addition of 0.5% dithionite in 5% sodium bicarbonate (100 µl) to a 
final volume of 1 ml followed by quenching with 88% formic acid (50 µl). (A) dmIYD 
only (0.2 µM). (B) Tyr (20 µM) and dmIYD (0.08 µM). (C) I-Tyr (40 µM). (D) Br-Tyr (40 











        
Figure B6. Steady-state analysis of halotyrosine turnover by dmIYD. Initial rate of 
dehalogenation was determined by quantifying Tyr product. Each data point represents an 
average of 3 individual observations and the error bars represent the standard deviation 
from those averages. Kinetic constants are derived from the best fit of the data (solid lines) 
to the Michealis-Menten equation. All nonlinear curve fitting was performed using Origin 






















                    
 
Figure B7. Potential defluorination of F-Tyr by dmIYD was monitored with reverse phase 
HPLC. Assay conditions were equivalent to those used for evaluating turnover of other 
halotyrosines i.e. 30 µM m-cresol, 200 mM KCl, 100 mM potassium phosphate pH 7.4 
with addition of 0.5% dithionite in 5% sodium bicarbonate (100 µl) to initiate enzyme 
reduction followed by addition of 88% formic acid (50 µl) after 2 h to quench the reaction. 
(A) F-Tyr (200 µM) incubated with dmIYD (5 µM). (B) F-Tyr (200 µM) incubated with 
tyrosine standard (20 µM). The FMN signal is derived from dmIYD. No Tyr product was 









         
 
Figure B8. Steady-state analysis 125I-(I2-Tyr) turnover by dmIYD and its mutants. Initial 
rate of deiodination was determined by quantifying 125I- released by enzyme. Each data 
point represents an average of 3 independent observations and the error bars represent the 
standard deviation from that average. Kinetic constants are derived from the best fit of the 
data (solid lines) to the Michealis-Menten equation. All nonlinear curve fitting was 
performed using Origin 6.0. Enzyme concentration represents the total protein 





























































Figure C1. Sequence of CG6279 (genomic locus 3L, 11093371 to 11096245). The region 
targeted by UAS-105378 RNAi (isoform A) is indicated in yellow. The region targeted by 
UAS-37267 RNAi (isoform A and B) is indicated in blue. Both RNAi expressing fly strains 














































Figure C2. Sequence of CG6279 (genomic locus 3L, 11093371 to 11096245). The region 
targeted by UAS-shmiRNA-A (isoform A) is indicated in yellow. The region targeted by 
UAS-shmiRNA-AB (isoforms A and B) is indicated in blue. The region targeted by UAS-
shmiRNA-B (isoform B) is indicated in green. Start and stop codons of the gene are 


















































Figure D1. CRISPR sites selected within CG6279 gene (genomic locus 3L, 11093371 to 
11096245). The two CRISPR sites chosen for gene deletion are highlighted in blue and 
green. The 1st nucleotide of the active site Glu codon is indicated in pink. CRISPR site 
closest to active site Glu codon is indicated in yellow. All PAMs are highlighted in red. 
The start codon and the stop codon are highlighted in grey. The gRNAs recognize the 
antisense strand for CRISPR sites indicated in blue and green and the sense strand for 





Figure D2. Analysis of potential off-targets for selected CRISPR sites.112 All mis-matches 
with CRISPR gRNA are indicated in red. The PAM is separated from the CRISPR target 




ssODNs                                              Sequence 5’ to 3’ 
 










Figure D3. Single-stranded oligonucleotide templates (ssODN) for homology-directed 
repair (HDR) used in conjunction with gRNAs. Oligonucleotide 1 is designed for repair 
following gene deletion by cleavage at 5’ and 3’ CRISPR sites (blue and green sites 
indicated in Fig. D1). EcoRI restriction site for potential screening is indicated in red. 
Oligonucleotide 2 is designed to introduce a G to C (red) mutation changing a Glu codon 
to Gln. A silent mutation destroying PAM is indicated in grey. Additional highlighted 
sequences correspond to partial or complete CRISPR sites shown in Fig. D2. 
 
         CRISPR target        Chromosomal 
           location 
    Target  
  Direction  
   Status 
GCTTCAGTAGCGTCACATTC GGG 3L:11096065..11096087 Anti-sense On target 
GCTGAAGCAGCGGCACATTC CGG X:6826309..6826331 Sense Off target 
ATTTTAGTAGCGTTACATTC CGG 3L:23182180..23182202 Sense Off target 
GTTTTACTAGCGTCACTTTC GGG 2R:7104845..7104867 Anti-sense Off target 
GCAGCAGCAGCGTCACGTTC CGG X:5683924..5683946 Anti-sense Off target 
GCTTGCTGGGCGTCACATTC TGG X:6324699..6324721 Sense Off target 
    
GGAACTGTGCATCCATCTTT CGG 3L:11093479..11093501 Anti-sense On target 
ATAATTGTGCATCCATCTTG TGG 2R:8105299..8105321 Anti-sense Off target 
TCAGCTGACCATCCATCTTT AGG 2L:8518308..8518330 Sense Off target 
GCGAATGAGCTTCCATCTTT CGG 3R:31530841..31530863 Sense Off target 
TTAATTGGGCATCAATCTTT CGG 3L:16887531..16887553 Anti-sense Off target 
TGCAAGGTGCATCCATCGTT AGG X:21420176..21420198 Anti-sense Off target 
GGAACTTTGCCTGCATCTTT GGG 2L:6454470..6454492 Anti-sense Off target 
    
AGCTGGTCAACTACAGCCAG AGG    3L:11093814..11093836 Sense On target 
AGGGAGTCATCTACAGCCAG GGG 3L:20417543..20417565 Anti-sense Off target 
CGCTGCACAACTACATCCAG AGG 3R:30853839..30853861 Anti-sense Off target 
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